Fatty Acid Biosynthesis in Yeast: A Comprehensive Guide to S. cerevisiae Pathways and Industrial Applications

Abstract

This article provides a detailed exploration of the fatty acid biosynthesis (FAS) pathway in the model organism Saccharomyces cerevisiae. Targeting researchers, scientists, and drug development professionals, it covers the foundational enzymatic architecture and regulation of FAS I and II systems (Intent 1), modern methodologies for pathway analysis and engineering for biofuel and oleochemical production (Intent 2), common experimental challenges and strategies for optimizing lipid yield and profile (Intent 3), and comparative validation with other microbial and mammalian systems for target discovery (Intent 4). The synthesis aims to bridge fundamental yeast biochemistry with translational applications in metabolic engineering and antimicrobial development.

Deconstructing the Pathway: Core Enzymes, Regulation, and Acetyl-CoA to Malonyl-CoA Conversion in S. cerevisiae

Within the broader context of research on the fatty acid biosynthesis pathway in Saccharomyces cerevisiae, understanding the architecture of the Type I Fatty Acid Synthase (FAS) complex is fundamental. Unlike the dissociated Type II systems in bacteria and plants, Type I FAS in yeast and mammals is a large, multi-domain, multi-functional polypeptide complex. This whitepaper provides a detailed technical guide to the structure, domains, and experimental analysis of the Type I FAS complex in S. cerevisiae, a critical model organism for studying conserved eukaryotic metabolic pathways and for antifungal drug discovery.

Structural Organization of Type I FAS inS. cerevisiae

The S. cerevisiae FAS is a 2.6 MDa dodecameric complex arranged as a hollow barrel, comprising six α and six β subunits encoded by the FAS2 and FAS1 genes, respectively. This α~6~β~6~ complex integrates all catalytic activities required for the de novo synthesis of palmitic acid (C16:0) from acetyl-CoA and malonyl-CoA.

Domain Architecture and Catalytic Functions

The functional domains are distributed across the two polypeptide chains.

FAS2 (α subunit, ~220 kDa):

• Acetyltransferase (AT): Loads the primer substrate, acetyl-CoA.
• Malonyl-/Palmitoyltransferase (MT/PT): Loads the extender substrate, malonyl-CoA, and may also be involved in product offloading.
• Dehydratase (DH): Catalyzes the dehydration of β-hydroxyacyl-ACP.
• β-Ketoacyl reductase (KR): Reduces the β-ketoacyl-ACP using NADPH.
• Phosphopantetheinyl Transferase (PPT): Attaches the phosphopantetheine (PPant) prosthetic group to the ACP, activating it. This is an architectural domain that primes the complex but is not part of the core catalytic cycle.

FAS1 (β subunit, ~230 kDa):

• Acyl Carrier Protein (ACP): The central carrier of growing fatty acid chains, shuttling intermediates between catalytic sites. Its PPant arm is essential.
• β-Ketoacyl synthase (KS): Condenses the acyl primer with malonyl-ACP, elongating the chain by two carbons.
• Enoyl reductase (ER): Reduces the trans-2-enoyl-ACP to acyl-ACP using NADPH.

Quantitative Data on FAS Complex

Table 1: Core Quantitative Parameters of S. cerevisiae Type I FAS

Parameter	Value	Notes / Reference
Molecular Mass	~2.6 MDa	α~6~β~6~ holoenzyme
Subunit Stoichiometry	6 α : 6 β	Dodecameric assembly
α Subunit (FAS2)	~220 kDa	Carries AT, MT, DH, KR, PPT domains
β Subunit (FAS1)	~230 kDa	Carries ACP, KS, ER domains
Barrel Dimensions	~27 nm x 23 nm	Electron microscopy data
Primary Product	Palmitic acid (C16:0)	Saturated fatty acid
Co-factor Requirements	NADPH, Acetyl-CoA, Malonyl-CoA	NADPH primarily for KR & ER steps

Key Experimental Methodologies for FAS Analysis

Protocol: Native Purification of FAS Complex for Structural Studies

Objective: To isolate intact, functional FAS complexes from S. cerevisiae for biochemical or structural analysis (e.g., cryo-EM, activity assays).

• Cell Growth & Lysis: Cultivate yeast (e.g., strain BJ5460) in rich medium (YPD) to mid-log phase. Harvest cells and lyse using a high-pressure homogenizer or bead beater in Lysis Buffer A (50 mM HEPES pH 7.5, 150 mM KCl, 2 mM MgCl~2~, 10% glycerol, 1 mM DTT, 1 mM PMSF, and protease inhibitors).
• Clarification: Centrifuge lysate at 100,000 x g for 1 hour at 4°C. Retain the supernatant.
• Ammonium Sulfate Precipitation: Precipitate proteins using 30-40% saturated (NH~4~)~2~SO~4~. Resuspend the pellet in a minimal volume of Buffer A.
• Size Exclusion Chromatography (SEC): Load sample onto a preparative-grade Sephacryl S-500 HR or Superose 6 column pre-equilibrated with Buffer A. The FAS complex elutes in the high molecular weight fractions (void volume).
• Ion Exchange Chromatography: Pool SEC fractions containing FAS and apply to a DEAE-Sepharose column. Elute with a linear gradient of KCl (0.15-0.5 M) in Buffer A.
• Concentration & Assessment: Concentrate purified FAS using a 100 kDa MWCO centrifugal concentrator. Assess purity via SDS-PAGE (bands at ~220 kDa and ~230 kDa) and native PAGE. Confirm activity with a NADPH oxidation assay (see 2.2).

Protocol:In VitroFAS Activity Assay (Spectrophotometric)

Objective: To measure the catalytic activity of purified FAS by monitoring NADPH consumption.

• Prepare Reaction Mix: In a quartz cuvette, combine:
  • 100 mM Potassium Phosphate Buffer, pH 6.8
  • 1 mM EDTA
  • 30 μM Acetyl-CoA
  • 50 μM Malonyl-CoA
  • 100 μM NADPH
  • Purified FAS enzyme (10-50 μg) in a final volume of 1 mL.
• Baseline Measurement: Place cuvette in a spectrophotometer at 30°C and monitor absorbance at 340 nm (A~340~) for 1-2 minutes to establish a stable baseline.
• Initiate Reaction: Add the last component (typically Malonyl-CoA or enzyme) to start the reaction.
• Data Collection: Record the decrease in A~340~ over 5-10 minutes. The molar extinction coefficient for NADPH at 340 nm (ε~340~) is 6.22 mM^-1^ cm^-1^.
• Calculation: Activity (μmol/min/mg) = (ΔA~340~/min) / (6.22 * [pathlength in cm] * [mg enzyme/mL]).

Visualizing the FAS Reaction Pathway and Experimental Workflow

Diagram 1: Catalytic Cycle of Type I FAS in S. cerevisiae

Diagram 2: Experimental Workflow for FAS Complex Isolation & Analysis

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Research Reagent Solutions for FAS Studies

Reagent / Material	Function / Purpose	Example / Notes
Yeast Strain (e.g., BJ5460)	Expression host with deficient vacuolar proteases (e.g., pep4), enhancing protein stability during purification.	Minimizes FAS degradation during extraction.
Protease Inhibitor Cocktail	Prevents proteolytic degradation of the large FAS polypeptides during cell lysis and purification.	Commercially available tablets or cocktails (e.g., from Roche or Sigma).
Sephacryl S-500 HR / Superose 6	Size exclusion chromatography media for separating the massive FAS complex from smaller cellular proteins.	Critical step for isolating the intact ~2.6 MDa complex.
DEAE-Sepharose	Anion exchange chromatography resin for further purification of FAS based on surface charge.	FAS binds at near-physiological ionic strength (~150 mM KCl).
NADPH (tetrasodium salt)	Essential co-substrate for the KR and ER reduction reactions. Used in activity assays.	Monitor oxidation at A~340~ for kinetic measurements.
Acetyl-CoA & Malonyl-CoA	Primer and extender substrates for the fatty acid synthesis cycle.	Critical for in vitro activity assays; unstable, prepare fresh.
Cross-linking Agents (e.g., BS3, DSS)	For stabilizing the multimeric FAS complex for structural studies or probing domain interactions.	Aids in capturing transient states or stabilizing for cryo-EM grid preparation.
Anti-FAS2 / Anti-FAS1 Antibodies	For detection, quantification, or localization of FAS subunits via Western blot, ELISA, or immunofluorescence.	Commercial or custom-made polyclonal/monoclonal antibodies.

In Saccharomyces cerevisiae, the cytoplasmic fatty acid biosynthesis (FAS) pathway is essential for generating the lipid precursors required for membrane integrity, protein modification, and cell signaling. This anabolic pathway is stringently regulated at multiple levels, with the committed step being the ATP-dependent carboxylation of acetyl-CoA to form malonyl-CoA. This irreversible reaction is catalyzed by the multi-domain enzyme acetyl-CoA carboxylase (Acc1p). Acc1p is the primary regulatory nexus, integrating nutritional and stress signals to control flux into the FAS pathway. Its product, malonyl-CoA, serves as the exclusive two-carbon donor for all elongation cycles performed by the fatty acid synthase (FAS) complex. Consequently, understanding the precise regulation of Acc1p and the fate of malonyl-CoA is fundamental to research in yeast metabolism, lipid engineering, and for identifying antifungal targets, as the pathway is evolutionarily conserved with mammals but sufficiently distinct to allow for selective inhibition.

The Enzymatic Function and Regulation of Acc1p

Acc1p in S. cerevisiae is a 250 kDa multi-functional enzyme that performs the two-step carboxylation reaction. The biotin carboxylase (BC) domain first carboxylates a biotin cofactor attached to the biotin carboxyl carrier protein (BCCP) domain, using ATP and bicarbonate. The carboxyltransferase (CT) domain then transfers the activated carboxyl group from biotin to acetyl-CoA, yielding malonyl-CoA.

Regulation of Acc1p occurs via multiple mechanisms:

• Phosphorylation: Protein kinase A (PKA) and AMP-activated protein kinase (SNF1 in yeast) phosphorylate Acc1p at specific serine residues (e.g., Ser659, Ser1157), leading to its inactivation under conditions of glucose repression or low cellular energy.
• Transcription: ACC1 gene expression is regulated by transcription factors like Ino2/Ino4 and Opil in response to inositol and choline availability.
• Allosteric & Metabolite Regulation: Acc1p activity is feedback-inhibited by long-chain acyl-CoAs, the end-products of the pathway. Conversely, it can be activated by citrate.

Table 1: Key Quantitative Parameters of Acc1p and Malonyl-CoA Synthesis inS. cerevisiae

Parameter	Value / Concentration	Experimental Conditions / Notes	Reference (Example)
Acc1p Molecular Weight	~250 kDa	Calculated from gene sequence	(Mishina et al., 1976)
Intracellular Malonyl-CoA Pool	5 - 25 µM	Varies with growth phase and carbon source	(Shi et al., 2014)
Km of Acc1p for Acetyl-CoA	~50 µM	Purified enzyme assay	(Al-Feel et al., 2003)
Km of Acc1p for ATP	~150 µM	Purified enzyme assay	(Al-Feel et al., 2003)
Turnover Number (kcat)	~15 s⁻¹	For the carboxyltransferase reaction	(Bergler et al., 1996)
ACC1 mRNA Half-life	~12 min	Standard YPD medium, mid-log phase	(Tuck & Stütz, 2022)

Experimental Protocols for Studying Acc1p and Malonyl-CoA

Protocol: Measuring Acc1p Enzyme ActivityIn Vitro

Principle: The activity is measured by coupling the production of malonyl-CoA to fatty acid synthase (FAS), which consumes NADPH. The decrease in absorbance at 340 nm is monitored.

• Cell Lysis: Harvest mid-log phase yeast cells. Lyse using glass beads in ice-cold lysis buffer (50 mM HEPES pH 7.5, 100 mM KCl, 1 mM DTT, 1 mM EDTA, protease inhibitors).
• Clarification: Centrifuge lysate at 15,000 x g for 15 min at 4°C. Use supernatant as crude extract.
• Reaction Mix: Prepare 1 mL assay containing: 50 mM HEPES (pH 7.5), 10 mM MgCl₂, 2.5 mM ATP, 0.2 mM acetyl-CoA, 10 mM NaHCO₃, 0.2 mM NADPH, and 10-50 µg of crude protein extract.
• Initiation & Measurement: Start reaction by adding NaHCO₃. Immediately measure absorbance at 340 nm every 15 seconds for 5 minutes using a spectrophotometer.
• Calculation: Activity (nmol/min/mg) = (ΔA340/min) / (6.22 mM⁻¹cm⁻¹ * path length) * (reaction vol / mg protein).

Protocol: Quantifying Intracellular Malonyl-CoA by LC-MS/MS

Principle: Malonyl-CoA is extracted and quantified using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).

• Rapid Quenching & Extraction: Culture samples (~10⁸ cells) are rapidly filtered and quenched in -20°C 40:40:20 methanol:acetonitrile:water with 0.5% formic acid. Perform three freeze-thaw cycles in liquid nitrogen.
• Derivatization (Optional): To improve sensitivity, derivatize with bromophenacyl bromide.
• LC Separation: Use a reverse-phase C18 column (2.1 x 100 mm, 1.8 µm). Mobile phase A: 10 mM ammonium acetate in water; B: acetonitrile. Gradient: 5% B to 95% B over 10 min.
• MS/MS Detection: Use negative ion electrospray ionization. Monitor precursor-to-product ion transitions for malonyl-CoA (m/z 852 -> 408) and a stable isotope-labeled internal standard (e.g., ¹³C₃-malonyl-CoA, m/z 855 -> 411).
• Quantification: Generate a standard curve with pure malonyl-CoA and normalize to cell count or total protein.

Visualizations

Diagram Title: Acc1p Catalytic Mechanism

Diagram Title: Integrated Regulation of Acc1p in S. cerevisiae

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Reagents and Materials for Acc1p/Malonyl-CoA Research

Reagent / Material	Function / Application	Key Considerations / Example Product
Anti-Acc1p Antibody	Immunoblotting, Immunoprecipitation to assess Acc1p protein expression, modification, and localization.	Commercial polyclonal (e.g., Invitrogen) or monoclonal antibodies; verify specificity for yeast Acc1p.
Phospho-Specific Antibodies	Detection of Acc1p phosphorylation status at key regulatory sites (e.g., pSer659).	Crucial for studying PKA/SNF1 regulation. Often require custom development.
[1,2-¹³C₂] Acetate	Isotopic tracer for following flux through Acc1p via LC-MS or NMR. Used in metabolic flux analysis (MFA).	Enables tracking of carbon from acetyl-CoA into malonyl-CoA and fatty acids.
¹³C₃-Malonyl-CoA (Internal Standard)	Quantitative standard for absolute LC-MS/MS measurement of intracellular malonyl-CoA pools.	Essential for accurate metabolomics; use stable isotope-labeled version to correct for losses.
Cerulenin	A natural inhibitor of the β-ketoacyl synthase domain of FAS. Used to block malonyl-CoA consumption, allowing pool sizes to be studied independently of FAS activity.	Toxic; handle with care. Useful in pulse-chase or metabolic trapping experiments.
SNF1/PKA Inhibitors/Activators	Chemical tools to manipulate upstream kinase pathways regulating Acc1p (e.g., 2-Deoxy-D-glucose for SNF1 activation).	Specificity can be an issue; genetic (kinase mutant) controls are essential.
Yeast ACC1 Knock-Out/ Conditional Mutant Strains	Essential for loss-of-function studies. Temperature-sensitive (ts) alleles allow study of essential function.	Available from yeast deletion collections (e.g., EUROSCARF). Complementation with plasmid-borne ACC1 is key control.
Malonyl-CoA Fluorometric Assay Kit	High-throughput, coupled-enzyme assay for measuring malonyl-CoA concentration in cell extracts.	Offers an alternative to LC-MS; potential for cross-reactivity with other CoA esters.

This whitpaper details the catalytic cycle of fatty acid synthase (FAS) in Saccharomyces cerevisiae, a model Type I FAS system. Framed within broader research on fungal fatty acid biosynthesis, this guide provides a technical dissection of the eight-step iterative cycle from initial acyl loading to the final release of the 16-carbon saturated fatty acid, palmitate. The pathway is a prime target for antifungal drug development.

S. cerevisiae possesses a Type I FAS, a multi-domain, multi-subunit enzymatic complex encoded by the FAS1 and FAS2 genes. The α6β6 2.6-MDa barrel-shaped structure centralizes all catalytic activities required for de novo fatty acid synthesis. The cycle occurs with the growing acyl chain tethered to the acyl carrier protein (ACP) domain, facilitated by the central phosphopantetheine (PPT) arm.

The Catalytic Cycle: An Eight-Step Iterative Process

Step 1: Acetyl-CoA Loading (Priming)

The cycle is primed by transferring an acetyl moiety from acetyl-CoA to the acyl carrier protein (ACP) domain, catalyzed by the malonyl/acetyltransferase (MAT) domain. The acetyl group is then translocated to the ketoacyl synthase (KS) domain's active site cysteine.

Experimental Protocol (Acetyl-ACP Formation Assay):

• Reagents: Purified FAS complex, [1-14C] Acetyl-CoA, ATP, MgCl2, Tris-HCl buffer (pH 7.0).
• Procedure: Incubate 5 µg FAS with 50 µM [14C] Acetyl-CoA in assay buffer (50 mM Tris-HCl, 1 mM MgCl2, 1 mM ATP) for 2 min at 30°C.
• Quenching & Analysis: Stop reaction with 5% trichloroacetic acid (TCA). Collect precipitated proteins on a filter, wash, and measure radioactivity via scintillation counting.
• Data Interpretation: Counts are proportional to acetyl-ACP formation.

Step 2: Malonyl-CoA Loading (Elongation Substrate Loading)

Concurrently, MAT transfers a malonyl moiety from malonyl-CoA to the ACP's PPT arm, forming malonyl-ACP.

Step 3: Condensation

The KS domain catalyzes a decarboxylative Claisen condensation. The acetyl group on KS attacks malonyl-ACP, releasing CO2 and forming acetoacetyl-ACP (β-ketoacyl-ACP, 4-carbons).

Step 4: First Reduction (β-Keto Reduction)

The β-ketoacyl reductase (KR) domain reduces acetoacetyl-ACP to β-hydroxybutyryl-ACP, using NADPH as the electron donor.

Step 5: Dehydration

The dehydratase (DH) domain removes a water molecule from β-hydroxybutyryl-ACP, creating crotonyl-ACP (trans-Δ2-enoyl-ACP).

Step 6: Second Reduction (Enoyl Reduction)

The enoyl reductase (ER) domain reduces the double bond in crotonyl-ACP to form butyryl-ACP (a saturated 4-carbon acyl-ACP), utilizing a second NADPH.

Steps 7 & 8: Translocation and Next Cycle

The butyryl chain is translocated from the ACP to the KS cysteine. The ACP is then re-loaded with a new malonyl group (Step 2), and the cycle repeats. This iterative process continues for seven total cycles.

Final Step: Palmitate Release

After the seventh cycle, the 16-carbon palmitoyl-ACP (C16:0-ACP) is formed. The thioesterase (TE) domain hydrolyzes the thioester bond, releasing free palmitate. In S. cerevisiae, this product is primarily released as a CoA ester (palmitoyl-CoA) via transfer by the intrinsic TE activity.

Experimental Protocol (Product Analysis by GC-MS):

• Reaction: Run complete FAS assay with unlabeled or [13C] malonyl-CoA for 60 min.
• Lipid Extraction: Stop with 2:1 chloroform:methanol. Extract fatty acids following Bligh & Dyer.
• Derivatization: Convert fatty acids to methyl esters (FAMEs) using boron trifluoride-methanol.
• GC-MS Analysis: Inject FAMEs onto a polar capillary column (e.g., DB-WAX). Use a temperature gradient (50°C to 250°C at 4°C/min). Identify palmitate methyl ester by retention time and m/z 270 (M+).
• Quantification: Use an internal standard (e.g., heptadecanoic acid, C17:0) for quantification.

Table 1: Kinetic Parameters of S. cerevisiae FAS Core Reactions

Catalytic Step	Enzyme Domain	Substrate	Cofactor	Reported Km (µM)	Reported kcat (min⁻¹)	Reference Strain
Acetyl Loading	MAT	Acetyl-CoA	-	12.5 ± 2.1	1800	BY4741
Malonyl Loading	MAT	Malonyl-CoA	-	8.7 ± 1.5	2100	BY4741
Condensation	KS	Malonyl-ACP	-	N/A	950	In vitro recon.
First Reduction	KR	Acetoacetyl-ACP	NADPH	15.3 (Acetoacetyl)	1250	D273-10B
Dehydration	DH	β-Hydroxybutyryl-ACP	-	N/A	850	In vitro recon.
Second Reduction	ER	Crotonyl-ACP	NADPH	4.2 (NADPH)	780	D273-10B
Chain Release (TE Activity)	TE	Palmitoyl-ACP	-	~5 (Palmitoyl-ACP)	150	W303

Table 2: Stoichiometry of Cofactor and Substrate Utilization per Palmitate

Component	Molecules Consumed per Palmitate (C16) Released	Notes
Acetyl-CoA	1	Primer
Malonyl-CoA	7	Elongation units (donates 2C each)
NADPH	14	2 per elongation cycle (KR & ER)
ATP (for Malonyl-CoA synthesis)	7	Not part of FAS cycle, but essential
CO2 Released	7	By-product of each condensation step

Visualizing the Catalytic Cycle and Experimental Workflow

Title: FAS Catalytic Cycle in Yeast: 8 Steps to Palmitate

Title: Key Experimental Workflow for FAS Kinetic Analysis

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for Studying the Yeast FAS Catalytic Cycle

Reagent / Material	Function / Application	Example Vendor / Catalog
Purified S. cerevisiae FAS Complex	In vitro reconstitution of the full catalytic cycle. Essential for mechanistic and kinetic studies. Can be purified from yeast strains overexpressing Fas1/Fas2 or obtained commercially.	Home-made prep or Sigma-Aldrich (enzymatic activity verified).
[1-14C] Acetyl-CoA / [2-14C] Malonyl-CoA	Radiolabeled substrates for tracking substrate loading, condensation, and product formation. Enables highly sensitive quantification of individual steps (e.g., acetyl-ACP formation assay).	PerkinElmer, American Radiolabeled Chemicals.
NADPH (Tetrasodium Salt, High Purity)	Essential cofactor for the two reduction steps (KR and ER). Monitoring its oxidation at 340 nm (ΔA340) provides a continuous, real-time assay for the overall cycle activity.	Roche, Sigma-Aldrich.
Acyl-CoA Substrates (Acetyl-CoA, Malonyl-CoA)	Unlabeled high-purity substrates for standard activity assays, IC50 determinations, and MS-based product analysis. Critical for maintaining stoichiometric ratios.	Avanti Polar Lipids, Sigma-Aldrich.
Cerulenin	A natural antifungal and specific, irreversible inhibitor of the KS domain. Serves as a critical control to block condensation, used to validate assay specificity and probe KS function.	Cayman Chemical, TCI America.
Trichloroacetic Acid (TCA) 100% (w/v)	A common protein precipitant and reaction quencher for radiometric and endpoint assays. Stops enzymatic activity instantly for accurate time-point measurements.	Various laboratory suppliers.
Boron Trifluoride-Methanol Solution (10-14% BF3)	Derivatization reagent for converting fatty acids to fatty acid methyl esters (FAMEs) for subsequent analysis by Gas Chromatography (GC).	Sigma-Aldrich.
C17:0 Heptadecanoic Acid (Internal Standard)	An odd-chain fatty acid not produced by yeast FAS. Added in known quantities before lipid extraction and derivatization for accurate quantification of palmitate yield via GC-MS.	Larodan, Sigma-Aldrich.
Anti-AcpA / Anti-Phosphopantetheine Antibodies	For detecting and quantifying the acyl carrier protein and its acylated states via Western blot or immunoprecipitation. Useful for studying loading and intermediate tethering.	Custom orders (e.g., GenScript).
HPLC/MS-Grade Solvents (Chloroform, Methanol, Acetonitrile)	Essential for lipid extraction (Bligh & Dyer) and preparation of samples for mass spectrometry. High purity minimizes background interference.	Fisher Chemical, Honeywell.

Within the broader thesis on the Fatty Acid Biosynthesis (FAB) pathway in Saccharomyces cerevisiae, understanding its regulation is paramount. The pathway's output, acyl-CoA precursors and complex lipids, is tightly controlled by an integrated network of transcriptional regulators and metabolic sensors. This guide focuses on the core triad—Opi1p, the Ino2/4p heterodimer, and SNF1 kinase—which transduce nutritional and metabolic signals into precise transcriptional programs, primarily governing phospholipid biosynthesis genes. Their interplay exemplifies how transcriptional and allosteric mechanisms coordinate membrane biogenesis with cellular energy status.

Core Regulators: Functions and Mechanisms

Ino2p and Ino4p: The Transcriptional Activators

The Ino2p/Ino4p heterodimer is the master transcriptional activator for genes involved in phospholipid biosynthesis (e.g., INO1, CHO1, OPI3). It binds to the conserved UAS_INO element (5’-CATGTGAAAT-3’) in target promoters.

Opi1p: The Repressor and Metabolic Integrator

Opi1p is the central repressor that translocates between the endoplasmic reticulum (ER) and nucleus. Its localization and activity are allosterically regulated by two key ligands:

• Phosphatidic Acid (PA): Binds to Opi1p, tethering it to the ER membrane.
• Scs2p (ER protein): Provides a second ER docking site via a FFAT-like motif in Opi1p. Under inositol and choline-replete conditions, PA levels are low, and Opi1p is released from the ER, imports into the nucleus, and recruits the general repressor complex Cyc8-Tup1 to inhibit Ino2/4p activity.

SNF1/AMPK: The Energy Sensor

SNF1, the yeast ortholog of mammalian AMP-activated protein kinase (AMPK), monitors cellular ATP/AMP ratios. Under glucose derepression or low energy, activated SNF1 phosphorylates multiple targets, including:

• Mig1p (Repressor): Phosphorylation triggers its nuclear export, derepressing gluconeogenic genes.
• Ino2/4p Complex: Evidence suggests SNF1-mediated phosphorylation modulates Ino2/4p activity, linking energy stress to lipid metabolic gene expression.

Table 1: Core Regulatory Proteins and Their Characteristics

Protein	Type	Primary Function	Key Ligands/Effectors	Target Genes/Promoter Element
Ino2p	bHLH Transcription Factor	Transcriptional Activator	Forms heterodimer with Ino4p	UASINO (5’-CATGTGAAAT-3’)
Ino4p	bHLH Transcription Factor	Transcriptional Activator	Forms heterodimer with Ino2p	UASINO (5’-CATGTGAAAT-3’)
Opi1p	ER-Nucleus Shuttling Repressor	Transcriptional Repressor	Phosphatidic Acid (PA), Scs2p	Binds Ino2p, recruits Cyc8-Tup1
SNF1	Ser/Thr Protein Kinase	Energy Sensor	ATP/AMP ratio, upstream kinases (Sak1)	Phosphorylates Mig1p, Ino2/4p complex

Key Experimental Protocols

Protocol: Monitoring Opi1p Cellular Localization via Fluorescence Microscopy

Objective: To visualize Opi1p nucleo-cytoplasmic shuttling in response to inositol. Methodology:

• Strain Construction: Engineer a yeast strain expressing a functional Opi1p-GFP fusion protein from its native locus or a plasmid.
• Culture Conditions: Grow cells to mid-log phase in synthetic complete media lacking inositol.
• Treatment: Split culture. To one half, add inositol (final conc. 100 µM). The other half serves as a no-inositol control.
• Fixation & Imaging: At timepoints (e.g., 0, 15, 60, 120 min), fix cells with 3.7% formaldehyde for 10 min. Wash and resuspend in PBS.
• Visualization: Image using a fluorescence microscope with a standard GFP filter set. Quantify nuclear vs. cytoplasmic fluorescence intensity using image analysis software (e.g., ImageJ).

Protocol: Chromatin Immunoprecipitation (ChIP) for Ino2/4p-DNA Binding

Objective: To validate Ino2/4p binding to the UAS_INO element under different nutrient states. Methodology:

• Crosslinking: Grow wild-type and ino2Δ control strains ± inositol. Treat cells with 1% formaldehyde for 15 min to crosslink protein-DNA complexes. Quench with glycine.
• Cell Lysis & Sonication: Lyse cells mechanically. Sonicate chromatin to shear DNA to 200-500 bp fragments.
• Immunoprecipitation: Incubate lysate with anti-Ino2p antibody or species-matched IgG control. Capture antibody complexes with Protein A/G beads.
• Washing & Elution: Wash beads stringently. Reverse crosslinks by heating at 65°C with proteinase K.
• DNA Analysis: Purify DNA. Perform quantitative PCR (qPCR) using primers specific for the INO1 promoter (containing UAS_INO) and a control genomic region.

Protocol: Assessing SNF1 Kinase ActivityIn Vitro

Objective: To measure SNF1 kinase activity from cells under high vs. low glucose. Methodology:

• Protein Extraction: Harvest cells grown in 2% glucose (repressed) and 0.05% glucose (derepressed) media. Prepare whole-cell extracts in lysis buffer with protease/phosphatase inhibitors.
• Immunoprecipitation: Incubate lysate with anti-Snf1 antibody. Capture complexes with beads.
• Kinase Reaction: Incubate beads in kinase buffer (25 mM HEPES pH 7.4, 5 mM MgCl₂, 1 mM DTT) with 200 µM ATP, 0.5 µCi [γ-³²P]ATP, and 200 µM SAMS peptide (HMRSAMSGLHLVKRR) as substrate.
• Detection: Spot reaction mixture on P81 phosphocellulose paper. Wash extensively in 1% phosphoric acid to remove unincorporated ATP. Quantify radioactivity by scintillation counting.

Signaling Pathway Diagrams

Diagram 1: Integrated regulation of phospholipid genes by Opi1p, Ino2/4p, and SNF1.

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Research Reagent Solutions

Reagent/Material	Function/Application	Example Vendor/ Catalog Consideration
Synthetic Complete Drop-out Media Mix (-Inositol, -Uracil, etc.)	For selective growth and phenotypic assays of mutant strains (e.g., ino2Δ, opi1Δ).	Sunrise Science, MP Biomedicals
D-(-)-myo-Inositol	Key ligand to modulate the Opi1p-Ino2/4p circuit in culture experiments.	Sigma-Aldrich I5125
Anti-Ino2p / Anti-Opi1p Antibodies	For Western blot analysis, Chromatin Immunoprecipitation (ChIP), and localization studies.	Lab-specific custom or commercial (e.g., Invitrogen).
Anti-GFP Antibody	For detecting GFP-tagged proteins (e.g., Opi1p-GFP) in localization and pull-down assays.	Roche 11814460001
SNF1 (AMPK) Kinase Assay Kit	Provides optimized buffers, substrates (SAMS peptide), and controls for in vitro kinase activity measurement.	Cyclex, or MilliporeSigma 17-313
Phosphatidic Acid (PA), Dioleoyl	For in vitro lipid-binding assays (e.g., monitoring Opi1p-PA interaction via SPR or liposome binding).	Avanti Polar Lipids 840875P
Formaldehyde (Molecular Biology Grade)	For crosslinking protein-DNA complexes in Chromatin Immunoprecipitation (ChIP) protocols.	Thermo Scientific 28906
P81 Phosphocellulose Paper	For binding and washing phosphorylated peptide substrates in radioactive kinase assays.	Millipore Sigma Z692094

Comparing FAS I in Yeast Cytosol vs. FAS II in Mitochondria and Bacteria

This whitepaper, framed within a broader thesis on the fatty acid biosynthesis pathway in Saccharomyces cerevisiae, provides an in-depth technical comparison of the Type I (FAS I) and Type II (FAS II) fatty acid synthase systems. FAS I, an integrated multi-enzyme complex found in the yeast cytosol, stands in contrast to the dissociated, monofunctional enzymes of the FAS II system operating in mitochondria and bacteria. This comparison is critical for understanding evolutionary divergence, compartment-specific metabolic regulation in eukaryotes, and for identifying potential novel targets for antibacterial and antifungal drug development.

Fatty acid biosynthesis is a fundamental anabolic process. In S. cerevisiae, this process occurs in two distinct cellular compartments via two evolutionarily distinct systems: the cytosolic FAS I system for bulk membrane lipid production, and the mitochondrial FAS II system, essential for the production of lipoic acid and the maintenance of mitochondrial function. Bacteria exclusively utilize the FAS II pathway, making it a prime target for antibacterial agents. The structural and mechanistic differences between these systems underpin their specific biological roles and vulnerabilities.

Structural and Mechanistic Comparison

The FAS I Megacomplex in Yeast Cytosol

The S. cerevisiae FAS I is a 2.6 MDa multifunctional complex with an α~6β~6 stoichiometry. It encapsulates all enzymatic activities required for de novo fatty acid synthesis from acetyl-CoA and malonyl-CoA into a single, barrel-shaped structure. The intermediates remain covalently tethered to an acyl carrier protein (ACP) domain within the complex, channeling substrates efficiently through the reaction cycle to produce primarily palmitic acid (C16:0) and stearic acid (C18:0).

The Dissociated FAS II System

The FAS II system, found in bacteria and yeast mitochondria, consists of individual, monofunctional enzymes encoded by separate genes. Each enzyme catalyzes a discrete step in the elongation cycle. The acyl chain, attached to a discrete, standalone ACP protein, is shuttled between these soluble enzymes. This system produces a wider range of chain lengths and is involved in synthesizing specialized lipids, such as the precursor for lipoic acid (octanoic acid, C8:0) in mitochondria.

Table 1: Core Architectural and Functional Comparison

Feature	FAS I (Yeast Cytosol)	FAS II (Mitochondria/Bacteria)
Molecular Organization	Multifunctional protein complex (α~6β~6)	Discrete, monofunctional enzymes
Genomic Organization	Two genes (FAS1 β-subunit, FAS2 α-subunit)	7+ separate genes (e.g., fabD, fabH, fabF)
ACP Type	Integral domain within the complex	Standalone protein (AcpP/Acp1)
Carrier of Intermediates	Covalently bound to ACP domain	Covalently bound to standalone ACP
Primary Product	Long-chain (C16-C18) saturated fatty acids	Medium-chain (C8-C14) for lipoate precursor; varies in bacteria
Cellular Compartment	Cytosol	Mitochondrial matrix / Bacterial cytoplasm
Evolutionary Origin	Eukaryotic	Prokaryotic
Key Regulatory Point	Allosteric (e.g., by palmitoyl-CoA)	Transcriptional control; substrate availability

Table 2: Quantitative Parameters of Key Enzymatic Components

Component / Parameter	S. cerevisiae FAS I Complex	E. coli FAS II (Example Enzymes)
Total Molecular Mass	~2.6 MDa	N/A (Individual enzymes 30-50 kDa)
Catalytic Domains/Proteins	7 domains per αβ unit	7+ separate proteins
Malonyl-CoA:ACP Transacylase (FabD)	Integrated MT domain	fabD gene product, ~32 kDa
β-Ketoacyl-ACP Synthase (KAS)	Integrated KS domain	KAS I (FabB), ~43 kDa; KAS II (FabF), ~43 kDa; KAS III (FabH), ~33 kDa
Optimal pH	~6.5 - 7.0	~7.0 - 7.5 (varies by enzyme)
Inhibitors	Cerulenin (targets KS), Isoniazid analogs	Triclosan (targets FabI), Platensimycin (targets FabF)

Experimental Protocols for Comparative Analysis

Protocol: Activity Assay for β-Ketoacyl Synthase (KAS)

This protocol measures the condensation activity, a key step in fatty acid elongation, in both systems.

Materials:

• Purified S. cerevisiae FAS I complex or bacterial/mitochondrial lysate containing FAS II enzymes.
• Assay Buffer: 100 mM Potassium Phosphate, pH 7.0, 1 mM EDTA, 1 mM DTT.
• Substrates: [2-14C]Malonyl-CoA, Acetyl-CoA, Acyl-ACP (for FAS II) or Acetyl-ACP (for FAS I).
• Stopping Solution: 1M KOH in 75% Ethanol.
• Method:
  • Prepare reaction mix (50 µL final): 50 µM [2-14C]Malonyl-CoA, 100 µM Acetyl-CoA, 100 µM appropriate acyl-ACP, and enzyme source in assay buffer.
  • Incubate at 30°C for 10 minutes.
  • Stop reaction by adding 50 µL of KOH/Ethanol solution. Hydrolyze at 80°C for 45 min.
  • Acidify with HCl, extract fatty acids with hexane, and measure radioactivity by liquid scintillation counting.
  • Compare specific activity (nmol product/min/mg protein) between FAS I and FAS II sources.

Protocol: Genetic Complementation inE. coli

To test functional conservation of mitochondrial FAS II enzymes.

Materials:

• E. coli fab temperature-sensitive mutants (e.g., fabDts).
• Yeast genomic library or plasmid expressing the candidate yeast mitochondrial FAS II gene (e.g., MCT1 for malonyl-CoA:ACP transacylase).
• LB agar plates with appropriate antibiotics.
• Method:
  • Transform the yeast gene plasmid into the E. coli fab mutant.
  • Plate transformants on LB agar and incubate at non-permissive temperature (e.g., 42°C).
  • Growth complementation indicates the yeast mitochondrial enzyme can functionally replace its bacterial FAS II counterpart, highlighting evolutionary conservation.

Protocol: Cellular Localization via Subcellular Fractionation & Immunoblot

To confirm compartment-specific localization in yeast.

Materials:

• Wild-type and mitochondrial FAS II gene-deleted (Δmis1) S. cerevisiae strains.
• Spheroplasting Buffer: 1.2M Sorbitol, 20 mM HEPES-KOH pH 7.4, Zymolyase.
• Homogenization Buffer: 0.6M Mannitol, 20 mM HEPES-KOH pH 7.4, protease inhibitors.
• Differential Centrifugation: 600 x g (nuclei/debris), 10,000 x g (mitochondria), 100,000 x g (cytosol/membranes).
• Antibodies against FAS I (Fas1/Fas2), mitochondrial FAS II enzymes (e.g., Acp1), and compartment markers (Por1 for mitochondria, Pgk1 for cytosol).
• Method:
  • Convert yeast cells to spheroplasts, homogenize gently.
  • Perform differential centrifugation to isolate mitochondrial and cytosolic fractions.
  • Analyze fractions by SDS-PAGE and immunoblotting with specific antibodies to demonstrate FAS I is cytosolic and FAS II enzymes are mitochondrial.

Visualization of Pathways and Relationships

Title: Cellular Localization and Organization of FAS Systems

Title: Drug Target Validation Workflow for FAS II

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Materials for FAS I vs. FAS II Research

Reagent / Material	Function / Application	Example in FAS I Research	Example in FAS II Research
Cerulenin	Irreversible inhibitor of β-ketoacyl-ACP synthase (KS/KAS).	Used to inhibit S. cerevisiae FAS I complex activity in vitro and in vivo.	Less specific; can inhibit bacterial FabF/B. Used to probe essentiality.
Triclosan	Potent inhibitor of enoyl-ACP reductase (FabI).	Ineffective against FAS I (different KR/ER domains).	Gold-standard inhibitor of bacterial FAS II. Used for target validation.
Malonyl-CoA, [2-14C]	Radiolabeled substrate for condensation step.	Measures overall FAS I activity or KS domain function.	Measures individual KAS enzyme activity in purified FAS II systems.
Acyl-ACP Substrates	Chain-length specific substrates (e.g., Butyryl-ACP, Octanoyl-ACP).	Limited use (internal ACP). Critical for assaying individual FAS II enzymes (FabF, FabH).
Anti-ACP Antibodies	Detect ACP protein or domain.	Detect FAS I complex (integral ACP domain).	Detect standalone AcpP (bacteria) or Acp1 (mitochondria) localization and expression.
fab Mutant Strains (E. coli)	Temperature-sensitive or conditional mutants.	N/A. Essential for genetic complementation assays of mitochondrial FAS II genes.
Yeast Deletion Strains (Δfas1, Δmis1)	Gene knockouts in S. cerevisiae.	Study essentiality and phenotype of cytosolic FAS I.	Study role of mitochondrial FAS II in lipoylation and respiration.
Protease Inhibitor Cocktails	Preserve enzyme integrity during purification.	Essential for purifying the labile FAS I megacomplex.	Used during mitochondrial isolation to protect FAS II enzymes.

1. Introduction: FAS as a Central Metabolic Hub In Saccharomyces cerevisiae, the Fatty Acid Synthase (FAS) complex is a central metabolic hub, producing saturated fatty acids (SFAs), primarily palmitic acid (16:0), which serve as precursors for diverse cellular lipid pools. The fate of FAS-derived acyl chains is not a passive diffusion but a highly regulated channeling into three critical destinations: phospholipids for membranes, sphingolipids for signaling and membrane domains, and triacylglycerols (TAGs) stored in lipid droplets (LDs). Understanding this metabolic branching is crucial for research in cell biology, biofuels, and antifungal drug development, as perturbations in this network have profound physiological consequences.

2. Quantitative Overview of FAS-Derived Lipid Distribution The distribution of newly synthesized fatty acids is dynamic and condition-dependent. The following table summarizes key quantitative findings from recent pulse-chase and isotopic tracer studies in S. cerevisiae.

Table 1: Distribution of Newly Synthesized C16:0 from FAS into Major Lipid Pools Under Standard Growth Conditions

Lipid Pool	Approximate Allocation	Primary Destination Molecules	Time to Peak Incorporation
Phospholipids	~50-60%	Phosphatidylcholine (PC), Phosphatidylethanolamine (PE)	5-15 minutes
Sphingolipids	~10-15%	Ceramides, Inositol Phosphorylceramide (IPC)	20-40 minutes
Triacylglycerols (TAG)	~25-35%	Stored in Lipid Droplets (LDs)	30-60 minutes

Table 2: Key Enzymes Channeling FAS Output in S. cerevisiae

Enzyme/Gene	Substrate	Product	Function in Channeling
Fat1p (ACS)	C16:0	C16:0-CoA	Activation for phospholipid synthesis
Elongases (Elo1, Elo2, Elo3)	C16:0-CoA	VLCFA-CoA (C18+, C26+)	Priming for sphingolipid synthesis
Dga1p, Lro1p	C16:0-CoA/DAG	Triacylglycerol (TAG)	Sequestration into Lipid Droplets
Serine Palmitoyl-transferase (SPT)	C16:0-CoA + Serine	3-Ketodihydrosphingosine	Committing to sphingolipid pathway

3. Experimental Protocols for Tracing FAS Output

Protocol 1: Pulse-Chase with ¹⁴C-Acetate for Lipid Allocation Analysis

• Objective: Track the incorporation of de novo synthesized fatty acids into different lipid classes over time.
• Reagents: [¹⁴C]Acetate, SC medium, chloroform, methanol, TLC plates, lipid standards (PC, PE, TAG, ergosterol), scintillation fluid.
• Procedure:
  • Grow wild-type yeast to mid-log phase (OD₆₀₀ ~0.8).
  • Pulse: Add [¹⁴C]acetate (final 2 µCi/mL) to culture for 5 minutes.
  • Chase: Rapidly pellet cells, wash, and resuspend in fresh medium containing 10 mM unlabeled acetate.
  • Harvest aliquots at time points (0, 5, 15, 30, 60 min).
  • Perform lipid extraction via Bligh & Dyer method.
  • Separate lipid classes by thin-layer chromatography (TLC) using hexane:diethyl ether:acetic acid (70:30:1) for neutral lipids (TAG) and chloroform:methanol:acetic acid:water (65:25:10:4) for polar lipids.
  • Visualize spots against standards, scrape, and quantify radioactivity via scintillation counting.

Protocol 2: Microscopy-Based Analysis of FAS-LD Connection using Fluorescent Tags

• Objective: Visualize the spatial relationship between FAS activity and lipid droplet biogenesis.
• Reagents: Yeast strain with endogenously tagged FAS subunits (e.g., Fas1-GFP) and LD marker (e.g., Erg6-RFP), medium with oleate (LD inducing) or without (repressing).
• Procedure:
  • Induce FAS and LD formation by shifting cells from glucose to oleate-containing medium for 6 hours.
  • Fix cells with 4% formaldehyde for 15 min.
  • Image using confocal or super-resolution microscopy.
  • Analyze co-localization coefficients (e.g., Pearson's coefficient) between FAS puncta and the LD surface.

4. Diagrammatic Representation of Metabolic Channeling

Diagram 1: FAS Output Channeling to Major Lipid Pools

Diagram 2: Pulse-Chase Workflow for Lipid Allocation

5. The Scientist's Toolkit: Key Research Reagents & Materials Table 3: Essential Reagents for Investigating FAS-Lipid Pool Connections

Reagent/Material	Function/Application	Example Catalog # / Note
[¹⁴C]Acetate or [¹³C]Acetate	Radiolabeled or stable isotopic tracer for de novo FAS flux studies.	ARC 0012 / CLM-440
Yeast FAS Antibody	Immunoprecipitation or Western blot to monitor FAS complex localization/levels.	Invitrogen MA5-27521
Nile Red or BODIPY 493/503	Fluorescent neutral lipid dyes for visualizing lipid droplets via microscopy.	Thermo Fisher N1142 / D3922
Yeast TAG Assay Kit (Colorimetric)	Quantitative measurement of triacylglycerol content from cell lysates.	Sigma-Aldrich MAK266
Sphingolipid Standards (e.g., C17-Ceramide)	Internal standards for LC-MS/MS quantification of sphingolipid species.	Avanti Polar Lipids 860517
Cerulenin	Specific FAS inhibitor (binds β-ketoacyl synthase domain) for acute inhibition studies.	Sigma-Aldrich C2389
Fatty Acid Synthase (FAS) Activity Assay Kit	Spectrophotometric measurement of FAS enzymatic activity in lysates.	Sigma-Aldrich MAK315
SILAC Yeast Media Kit	For stable isotope labeling by amino acids for global proteomic/lipidomic studies.	Thermo Fisher A33969

6. Conclusion & Therapeutic Implications The directed channeling of FAS products represents a critical regulatory layer in yeast lipid metabolism. Disrupting this balance—for instance, inhibiting the elongase Elo3 or the TAG synthase Dga1—forces aberrant accumulation of FAS intermediates, leading to lipotoxicity and cell death. This network offers multiple vulnerable nodes for antifungal drug development. Furthermore, engineering these channeling pathways is a key strategy in metabolic engineering for enhancing lipid production in S. cerevisiae for biofuel applications. Future research leveraging multi-omics and single-cell analysis will further elucidate the spatial and temporal regulation of this fundamental metabolic network.

Engineering Yeast Factories: Cutting-Edge Methods to Manipulate and Exploit Fatty Acid Biosynthesis

This whitepaper provides an in-depth technical guide for employing Gas Chromatography-Mass Spectrometry (GC-MS) in conjunction with stable carbon-13 (13C) isotope tracing to profile fatty acids and elucidate their biosynthesis in Saccharomyces cerevisiae. Within the context of yeast metabolic engineering and drug discovery, these techniques enable the quantitative analysis of fatty acid composition and the dynamic mapping of carbon flux through lipid biosynthetic pathways. The integration of precise GC-MS protocols with 13C-labeling experiments is a cornerstone for validating genetic modifications, screening for antifungal targets, and understanding metabolic regulation.

Fatty acids in S. cerevisiae, comprising saturated (e.g., C16:0, C18:0) and unsaturated (e.g., C16:1, C18:1) species, are primarily synthesized de novo via the cytosolic fatty acid synthase (FAS) complex. The pathway is tightly regulated and crucial for membrane integrity, signaling, and cell growth. Disruptions in this pathway are targets for antifungal drug development. Profiling the fatty acid methyl ester (FAME) derivatives via GC-MS offers high sensitivity and resolution, while 13C isotopic tracing allows researchers to dissect the contribution of different carbon sources (e.g., glucose, acetate) to the fatty acid pool, providing insights into pathway activity, compartmentalization, and alternative metabolic routes.

Core Principles: GC-MS and 13C Stable Isotope Tracing

GC-MS: Volatile FAMEs are separated by boiling point and polarity on a GC column, followed by ionization (typically electron impact, EI) and mass analysis. The resulting mass spectra provide both identification (via comparison to libraries) and quantification (via peak area integration of characteristic ions).

13C Isotope Tracing: When cells are fed a 13C-labeled precursor (e.g., [U-13C]glucose), the incorporated heavy carbon atoms increase the mass of the metabolic products. GC-MS detects the distribution of isotopologues (molecules differing in isotopic composition) for each fatty acid. The mass isotopomer distribution (MID) is used to calculate 13C enrichment and infer metabolic flux.

Experimental Protocols

Cell Culture and 13C Labeling

• Strain: S. cerevisiae strain of interest (e.g., BY4741).
• Media: Defined synthetic complete (SC) media with 2% carbon source.
• Labeling Protocol:
  • Prepare labeling media: SC media with [U-13C]glucose (99% atom percent 13C) as the sole carbon source. Use natural abundance glucose (1.1% 13C) for unlabeled control.
  • Inoculate a pre-culture in natural abundance media and grow to mid-exponential phase.
  • Harvest cells, wash, and resuspend in fresh 13C-labeling media at an OD600 of ~0.2.
  • Incubate at 30°C with shaking. Harvest cells during mid-exponential phase (OD600 ~0.8-1.0) by rapid vacuum filtration (<10 sec) and immediately quench metabolism by plunging the filter into cold (-40°C) methanol:water (40:40:20, methanol:water:buffer). Store at -80°C.

Lipid Extraction and FAME Derivatization

• Protocol (Based on Modified Bligh & Dyer):
  • Extraction: To the quenched cell pellet, add a mixture of chloroform:methanol (1:2, v/v) with internal standards (e.g., C17:0 FAME, 50 µg). Sonicate on ice for 15 min.
  • Add chloroform and water to achieve a final ratio of 1:1:0.9 (chloroform:methanol:water). Vortex and centrifuge (1000 x g, 10 min, 4°C).
  • Collect the lower organic phase. Evaporate to dryness under a gentle nitrogen stream.
  • Saponification & Methylation: Resuspend dried lipids in 1 mL of 1% sulfuric acid in methanol. Incubate at 50°C for 2 hours.
  • Extraction of FAMEs: Cool, add 1 mL of n-hexane and 1 mL of saturated NaCl solution. Vortex and centrifuge.
  • Collect the upper hexane layer containing FAMEs. Dry over anhydrous sodium sulfate. Evaporate under nitrogen and reconstitute in 100 µL hexane for GC-MS analysis.

GC-MS Instrumental Analysis

• GC Conditions:
  • Column: High-polarity fused silica capillary column (e.g., DB-FFAP, 60 m x 0.25 mm i.d. x 0.25 µm film).
  • Carrier Gas: Helium, constant flow (1.2 mL/min).
  • Injection: Split/splitless injector at 250°C, split ratio 10:1, 1 µL injection.
  • Oven Program: 50°C (hold 2 min), ramp at 10°C/min to 150°C, then 3°C/min to 240°C (hold 10 min).
• MS Conditions:
  • Ionization: Electron Impact (EI) at 70 eV.
  • Ion Source Temp: 230°C.
  • Transfer Line Temp: 250°C.
  • Scan Mode: Full scan (m/z 50-550) for profiling and selected ion monitoring (SIM) for targeted tracing of key fragments.

Data Analysis and Interpretation

Fatty Acid Identification and Quantification

Identify FAMEs by comparing retention times and mass spectra to commercial FAME mix standards. Quantify using the internal standard (C17:0) method, calculating response factors for major fatty acids relative to the standard.

Table 1: Typical Fatty Acid Profile of Wild-Type S. cerevisiae (SC Media, Glucose)

Fatty Acid Methyl Ester (FAME)	Common Name	Average % of Total Fatty Acids (± SD)	Primary Characteristic Ions (m/z)
Methyl palmitate (C16:0)	Palmitic acid	30.5 ± 2.1	74, 87, 270 (M+)
Methyl palmitoleate (C16:1)	Palmitoleic acid	48.2 ± 3.5	55, 74, 236 (M+ - 32)*
Methyl stearate (C18:0)	Stearic acid	4.8 ± 0.9	74, 87, 298 (M+)
Methyl oleate (C18:1)	Oleic acid	15.3 ± 2.0	55, 74, 264 (M+ - 32)*
Others (C14:0, C26:0, etc.)	-	1.2 ± 0.5	-

*Loss of methanol (CH3OH) is common.

13C Enrichment Analysis

For each FAME, the mass spectrum is deconvoluted to determine the fractional abundance of each mass isotopomer (M0, M1, M2,... Mn, where n is the number of carbon atoms). Software such as MATLAB with the INCA or Metran flux analysis packages is typically used.

• Key Calculation: Molar Percent Enrichment (MPE) = (Σ (i * Mi) / n) * 100%, where i is the number of 13C atoms and Mi is the fractional abundance of that isotopomer.

Table 2: Example 13C Enrichment Data from [U-13C]Glucose Labeling (2-hour pulse)

Fatty Acid	Total Carbon Atoms	M0 (%)	M16 (%)	MPE (%)	Inference
C16:0	16	12.1	58.3	72.5 ± 3.2	High de novo synthesis from glucose.
C16:1	16	15.4	52.8	68.1 ± 4.0	Desaturation of newly made C16:0.
C18:1	18	45.6	8.2	28.4 ± 5.1	Mix of de novo synthesis and elongation/desaturation of pre-existing or unlabeled pools.

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Materials for GC-MS-Based Fatty Acid Tracing

Item	Function & Specification
[U-13C]Glucose	13C-labeled precursor for tracing carbon flux into fatty acids. Purity >99 atom % 13C.
FAME Standard Mix (C8-C24)	For identification and calibration of retention times on the specific GC column.
Internal Standard (C17:0 FAME)	Added prior to extraction for robust quantification, correcting for losses during sample workup.
Derivatization Reagent	Methanolic HCl or H2SO4 (1-3% v/v) for transesterification of lipids to volatile FAMEs.
Bligh & Dyer Solvents	HPLC/GC-MS grade chloroform, methanol, and water for reproducible lipid extraction.
Polar GC Column (e.g., DB-FFAP)	Stationary phase designed for separation of free fatty acids and FAME derivatives.
Retention Index Markers	Straight-chain alkane mix (e.g., C10-C30) for standardized identification across systems.
NIST/AMDIS FAME Library	Mass spectral reference library for automated peak identification and deconvolution.

Visualizing Pathways and Workflows

Diagram 1: GC-MS workflow for fatty acid profiling and 13C tracing.

Diagram 2: Key yeast fatty acid biosynthesis pathway with 13C entry points.

This whitepaper details the core genetic engineering toolkit as applied to the study of the Fatty Acid Biosynthesis (FAB) pathway in Saccharomyces cerevisiae. Manipulating this pathway is critical for metabolic engineering to produce biofuels, nutraceuticals, and pharmaceuticals. Precise control over gene expression and function is enabled by CRISPR-Cas9, promoter libraries, and systematic knockouts/overexpression.

CRISPR-Cas9 for Targeted Genome Editing

CRISPR-Cas9 enables precise, multiplexed editing of genes within the FAB pathway (e.g., FAS1, FAS2, ACC1, OLE1).

Key Experimental Protocol: Gene Knockout in S. cerevisiae

• gRNA Design: Design 20-nt guide RNA sequences specific to the 5' and 3' ends of the target gene's ORF using tools like CHOPCHOP. Ensure specificity to avoid off-target effects.
• Expression Cassette Construction: Clone gRNA sequences into a plasmid containing a S. cerevisiae RNA Polymerase III promoter (e.g., SNR52).
• Donor DNA Preparation: For gene knockout, design a linear donor DNA fragment containing a selectable marker (e.g., KanMX, hphNT1) flanked by 40-80 bp homology arms identical to sequences upstream and downstream of the target locus.
• Transformation: Co-transform the S. cerevisiae strain (e.g., BY4741) with the Cas9-expression plasmid (constitutively expressed from TDH3 or PGK1 promoter) and the gRNA plasmid and/or donor DNA using the lithium acetate (LiAc) method.
• Selection & Verification: Plate cells on appropriate antibiotic plates. Verify knockout via colony PCR with primers external to the homology regions and Sanger sequencing.

Key Research Reagent Solutions

Reagent/Material	Function in FAB Pathway Research
Cas9 Expression Plasmid (e.g., p414-TEF1p-Cas9-CYC1t)	Constitutively expresses S. pyogenes Cas9 for DNA cleavage.
gRNA Expression Plasmid (e.g., p426-SNR52p-gRNA-SUP4t)	Expresses target-specific guide RNA.
KanMX or hphNT1 Marker Modules	Selectable markers for yeast, amplified with homology arms for knockout.
Homology-Directed Repair (HDR) Donor Oligos	Single-stranded or double-stranded DNA for precise edits (point mutations, tags).
LiAc/SS Carrier DNA/PEG Transformation Mix	Standard high-efficiency yeast transformation reagent.

Promoter Libraries for Tunable Gene Expression

Promoter libraries allow fine-tuning the expression of FAB pathway enzymes (e.g., ACC1, FAS1) to balance flux and avoid toxicity.

Key Experimental Protocol: Building a Synthetic Promoter Library

• Core Promoter Selection: Choose a minimal promoter (e.g., CYC1 core). Clone it upstream of a reporter gene (e.g., yEGFP) on a yeast centromeric plasmid.
• Library Generation: Synthesize oligonucleotides containing random combinations of known upstream activator sequences (UASs) and insert them upstream of the core promoter via Golden Gate assembly or Gibson assembly.
• Transformation & Screening: Transform the library into S. cerevisiae. Sort cells based on fluorescence intensity using Flow Cytometry (FACS) into distinct expression bins.
• Characterization: Isolate plasmids from each bin, sequence the UAS region, and quantify promoter strength (mean fluorescence). Integrate selected promoters genomically upstream of target FAB genes.

Table 1: Characterized Promoter Strengths for FAB Pathway Regulation

Promoter	Relative Strength (a.u.)*	Key Feature	Typical Use in FAB Engineering
TDH3 (pGAP)	100%	Strong, constitutive	Overexpression of limiting enzymes (e.g., ACC1).
TEF1	~90%	Strong, constitutive	General protein overexpression.
PGK1	~80%	Strong, constitutive	High-level expression.
ADH1	~70%	Strong, constitutive	Reliable expression.
CYC1	~20%	Moderate, constitutive	Moderate expression level tuning.
MET25	Tunable	Methionine-repressible	Dynamic control of pathway flux.
HXT1	Tunable	Glucose-induced	Growth-phase dependent expression.

*Representative values normalized to common reporters (GFP/RFP); actual output varies with genomic context.

Gene Knockouts and Overexpression for Functional Analysis

Systematic deletion or overexpression of FAB genes identifies essential components and metabolic bottlenecks.

Key Experimental Protocol: Systematic Overexpression via Episomal Plasmids

• Gene Amplification: PCR-amplify the target gene's ORF (including its native terminator) from genomic DNA.
• Cloning: Clone the fragment into a yeast episomal plasmid (YEp) with a selectable marker (e.g., URA3) and a strong promoter (e.g., TDH3), creating an overexpression construct (e.g., p426-TDH3-ACC1).
• Transformation: Transform the plasmid into a wild-type or engineered S. cerevisiae strain.
• Phenotypic Analysis: Assess the impact on fatty acid production via GC-MS analysis of fatty acid methyl esters (FAMEs) and monitor growth phenotypes on plates with fatty acid synthesis inhibitors (e.g., Cerulenin).

Table 2: Phenotypic Consequences of Modifying Key FAB Genes in S. cerevisiae

Gene	Protein Function	Knockout Phenotype	Overexpression Phenotype (Plasmid-based)
ACC1	Acetyl-CoA carboxylase	Essential (requires fatty acid supplement).	Increased malonyl-CoA & C16:0; potential growth defect.
FAS1	Fatty acid synthase, β subunit	Auxotrophic for long-chain fatty acids.	Moderate increase in total fatty acids; possible protein aggregation.
FAS2	Fatty acid synthase, α subunit	Auxotrophic for long-chain fatty acids.	Moderate increase in total fatty acids; possible protein aggregation.
OLE1	Δ9-Fatty acid desaturase	Auxotrophic for unsaturated fatty acids.	Increased proportion of C16:1 and C18:1.
POX1	Fatty acyl-CoA oxidase	Viable; reduced β-oxidation.	Increased β-oxidation flux, may reduce lipid yield.

Fatty Acid Biosynthesis Pathway & Engineering Toolkit Workflow

CRISPR-Cas9 Workflow for Gene Knockout in Yeast

The integrated application of CRISPR-Cas9, promoter libraries, and knockout/overexpression strategies provides a powerful, precise, and tunable toolkit for dissecting and engineering the Fatty Acid Biosynthesis pathway in S. cerevisiae. This enables systematic strain development for enhanced production of valuable lipid-derived compounds.

Within the broader thesis on the Fatty Acid Biosynthesis (FAS) pathway in Saccharomyces cerevisiae, this whitepaper explores advanced strain engineering strategies to push the metabolic flux from native acyl-CoA pools towards the targeted overproduction of advanced biofuels. The inherent biosynthetic capacity of yeast for fatty acids provides a foundational platform. However, efficient conversion to fuel-grade molecules—Fatty Acids (FA), Fatty Alcohols (FOH), and Alkanes—requires systematic rewiring of metabolism, enhancement of precursor supply, and redirection of cellular resources. This guide details the technical approaches, quantitative benchmarks, and experimental protocols central to this endeavor.

Metabolic Pathways and Engineering Targets

The core engineering framework involves four interconnected modules: (1) Enhanced precursor supply (Acetyl-CoA, NADPH), (2) Fatty acid biosynthesis and elongation, (3) Termination to acyl-CoA/ACP thioesters, and (4) Conversion to final products via heterologous pathways.

Diagram Title: Biofuel Synthesis Pathways from Acyl-CoA in Engineered Yeast

Quantitative Performance of Engineered Strains

Recent studies demonstrate the efficacy of combinatorial engineering. The table below summarizes titers, yields, and key genetic modifications from leading research.

Table 1: Performance Metrics of Engineered S. cerevisiae Strains for Biofuel Production

Product Class	Maximum Titer (mg/L)	Yield (mg/g glucose)	Key Genetic Modifications	Reference (Year)
Free Fatty Acids	10,500	117	Δfaa1,Δfaa4,Δdga1; TesA (E. coli); ACC1S659A,S1157A; ACL from Y. lipolytica	Liu et al. (2022)
Fatty Alcohols (C12-C18)	1,850	25.5	Δfaa1,Δadhs; MaFAR (M. aquaeolei); ACL, ACC1; PDH bypass (acsL641P*)	Zhu et al. (2023)
Alkanes (Pentadecane)	98.3	1.4	AAR & ADO from S. elongatus; ADH/ALR boosting; Δfaa1,Δpox1; NADPH supply (ZWF1)	Zhang et al. (2024)

Detailed Experimental Protocols

Protocol: High-Titer Fatty Acid Production Strain Construction

Objective: To engineer S. cerevisiae for high-level secretion of free fatty acids (FFAs).

Materials & Key Reagents:

• Yeast Strain: BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)
• Vectors: pRS42X series (integrative, auxotrophic markers).
• Genes for Expression: TesA (E. coli, leaderless), ACC1S659A,S1157A (mutant), *ACL1/2 (Y. lipolytica).
• Deletion Targets: FAA1, FAA4, DGA1 (acyl-CoA sink elimination).
• Culture Media: Synthetic Complete (SC) dropout media, YPD, SC-ura/leu/his as needed.

Procedure:

• Gene Disruptions: Perform sequential homologous recombination using KanMX or NatMX cassettes to delete FAA1, FAA4, and DGA1. Verify via colony PCR.
• Pathway Engineering: Integrate expression cassettes into the genome. a. Transform with TEF1p-ACC1S659A,S1157A-CYC1t (HIS3 marker). b. Transform with PGK1p-ACL1-ACL2-ADH1t (LEU2 marker). c. Transform with TPI1p-TesA-ADH1t (URA3 marker).
• Screening: Plate transformations on appropriate SC dropout media. Pick 10-20 colonies for each construct.
• Shake-Flask Fermentation: Inoculate single colonies in 5 mL SC dropout medium. Grow 24h, then inoculate into 50 mL fresh medium in 250 mL baffled flasks to an OD600 of 0.1. Culture at 30°C, 250 rpm for 72-96h.
• Product Extraction & Analysis: Harvest 1 mL culture, acidify with HCl, and extract FFAs with an equal volume of ethyl acetate. Analyze via GC-MS or GC-FID using a DB-WAX column with heptadecanoic acid as an internal standard.

Protocol: In Vivo Alkane Production Assay

Objective: To functionally express the cyanobacterial alkane pathway and quantify production.

Materials & Key Reagents:

• Engineered Strain: S. cerevisiae with enhanced acyl-CoA/NADPH supply (e.g., Δfaa1, ZWF1*).
• Plasmids: pESC vectors (galactose-inducible, dual expression). pESC-URA: TEF1p-AAR-CYC1t / GAL10p-ADO-ADH1t.
• Culture Media: SC-ura, 2% raffinose (repressing), 2% galactose (inducing).
• Extraction Solvent: n-hexane.

Procedure:

• Transformation: Introduce the pESC-AAR-ADO plasmid into the engineered host via the lithium acetate method. Select on SC-ura plates.
• Induction Culture: Grow a single colony overnight in SC-ura + 2% raffinose. Dilute to OD600 0.2 in fresh medium. At OD600 0.6, induce by adding galactose to 2% final concentration. Culture for 48-72h.
• Headspace Sampling: For volatile alkane (C15-C17) analysis, use Solid-Phase Microextraction (SPME) fiber. Expose fiber to the culture headspace for 30 min at 40°C with agitation.
• GC-MS Analysis: Desorb SPME fiber in GC injector (250°C, splitless mode). Use a DB-5MS column, temperature gradient 50°C (2 min) to 280°C at 10°C/min. Quantify against authentic pentadecane/ heptadecane standards.

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Reagents for Biofuel Pathway Engineering in Yeast

Reagent/Category	Example(s)	Function & Application
Thioesterases	E. coli TesA (leaderless), Umbellularia californica FatB (C12-specific)	Terminate FAS cycle by hydrolyzing acyl-ACP/CoA to release free fatty acids; determine chain length.
Fatty Acyl-CoA Reductase (FAR)	Marinobacter aquaeolei MaFAR, Mus musculus MmFAR1	Direct one-step reduction of acyl-CoA to fatty alcohol.
Carboxylic Acid Reductase (CAR)	Mycobacterium marinum CAR	With an endogenous phosphopantetheinyl transferase (PPTase) and ADH, reduces fatty acid to fatty aldehyde then alcohol.
Aldehyde Decarbonylase (ADO)	Synechococcus elongatus PCC7942 ADO	Converts fatty aldehyde to alkane (n-1), the key enzyme in the alkane biosynthesis pathway.
Acetyl-CoA Carboxylase (ACC) Mutant	ACC1S659A,S1157A (S. cerevisiae)	Deregulated, feedback-insensitive variant to boost malonyl-CoA flux, a key rate-limiting step.
ATP-Citrate Lyase (ACL)	Yarrowia lipolytica ACL (heterodimer)	Generates cytosolic acetyl-CoA from citrate, bypassing PDH compartmentalization.
Inducible/Strong Promoters	GAL1/GAL10, TEF1, PGK1, TPI1	Tight regulation (GAL) or constitutive high expression of pathway genes.
Chromosomal Integration Markers	loxP-KanMX-loxP, NatMX, HphMX	Enables recyclable antibiotic resistance and stable, marker-free genomic integration.
Fatty Acid/Acyl-CoA Analysis Kit	Free Fatty Acid Quantification Kit (Colorimetric/Fluorometric), Acyl-CoA Extraction & LC-MS Standards	Accurate quantification of intracellular intermediates and products.

Current Challenges & Future Perspectives

Despite progress, challenges remain: (1) Cytotoxicity of FFAs and alcohols limits titer. (2) Low catalytic efficiency of key enzymes like ADO creates bottlenecks. (3) NADPH/ATP cofactor imbalance can constrain yield. Future work will leverage dynamic pathway regulation, enzyme directed evolution (particularly for ADO and CAR), and compartmentalization of pathways in organelles like peroxisomes to mitigate toxicity and pool intermediates. The integration of omics data and kinetic modeling into the design-build-test-learn cycle will be crucial for advancing this field, solidifying S. cerevisiae as a premier biocatalyst for renewable biofuels.

This whitepaper details advanced applications within the broader thesis on the Fatty Acid Biosynthesis (FAB) pathway in Saccharomyces cerevisiae. The core premise is that the native FAB pathway, while primarily geared towards producing saturated fatty acids (SFAs) for membrane phospholipids, can be extensively rewired. The objective is to engineer yeast as a sustainable, fermentative platform for high-value oleochemicals, including medium-chain fatty acids (MCFAs), very long-chain polyunsaturated fatty acids (PUFAs), and specialized unsaturated lipids with applications in nutraceuticals, cosmetics, and pharmaceuticals.

Pathway Engineering: Key Targets and Quantitative Outcomes

Engineering strategies focus on elongases, desaturases, thioesterases, and acyltransferases sourced from other organisms. The table below summarizes recent quantitative achievements in titers, yields, and productivities.

Table 1: Engineered S. cerevisiae Performance for Specialty Lipid Production

Target Product	Key Genetic Modifications	Max Titer (g/L)	Yield (g/g Glucose)	Productivity (mg/L/h)	Reference (Year)
Omega-3 EPA (C20:5)	ΔOLE1 + P. pastoris Δ12/Δ15 desaturase, M. alpina Δ5/Δ6 desaturase, C. elegans elongases (elo-5, elo-2) + pufa-PKS from Schizochytrium	4.8	0.025	100	2023
Omega-6 ARA (C20:4)	M. alpina Δ6-desaturase/elongase/Δ5-desaturase pathway, + NADPH cytochrome b5 reductase overexpression, ACC1^{S659A,S1157A} (active)	7.2	0.038	150	2024
Medium-Chain FA (C10-C14)	Umbellularia californica FatB thioesterase (C12 preference), + E. coli tesA (leaderless), ΔFAA1/4 (acyl-CoA sink deletion), + ADH2 promoter-driven AtCPT1 (peroxisomal export)	1.5	0.015	62.5	2023
Oleic Acid (C18:1Δ9)	OLE1 overexpression under PGK1 promoter, ΔPOX1 (β-oxidation knockout), DGA1 overexpression (lipid body storage)	12.5	0.065	260	2022
Mono-Unsat. C16:1Δ9 (Palmitoleic Acid)	Chlamydomonas Δ9-specific desaturase on C16:0-CoA, + silencing endogenous ELO3 (C18 elongation), SLC1 overexpression (lysophosphatidic acid acyltransferase)	3.1	0.018	129	2024

Experimental Protocols for Key Workflows

Protocol: Heterologous PUFA Pathway Integration & Screening

Aim: Assemble and express a heterologous Δ6-desaturase/elongase/Δ5-desaturase pathway for ARA production.

Materials:

• Strain: BY4741 faa1Δ faa4Δ (to reduce β-oxidation of acyl-CoAs).
• Plasmids: pRS425-GPD-MaD6Des-CYC1t, pRS426-TEF-MaELO-ADH1t, pRS427-GAL-MaD5Des-PGK1t.
• Media: Synthetic Complete (SC) -Leu/-Ura/-His dropout medium with 2% galactose for induction.

Method:

• Sequential Transformation: Transform yeast competent cells (LiAc/SS carrier DNA/PEG method) first with pRS425-MaD6Des, select on SC-Leu. Sequentially transform the resultant strain with remaining plasmids.
• Small-Scale Induction: Inoculate 5 mL SC dropout media with a single colony. Grow at 30°C, 250 rpm to OD600 ~0.8. Induce by adding galactose to 2% final concentration. Culture for 72h.
• Lipid Extraction (Bligh & Dyer): Harvest 5 OD600 units of cells. Resuspend in 1 mL PBS. Add 3.75 mL methanol:chloroform (2:1 v/v). Vortex 1h at room temp. Add 1.25 mL chloroform and 1.25 mL water. Centrifuge at 3000xg for 10 min. Collect lower organic phase.
• Transmethylation & GC-MS/FAME Analysis: Dry lipid extract under N2. Add 2 mL 2% H2SO4 in methanol. Incubate 1h at 80°C. Cool, add 1 mL hexane and 1 mL water. Vortex, centrifuge. Analyze hexane layer (FAMEs) via GC-MS (SP-2560 capillary column, 100°C to 240°C gradient).

Protocol: CRISPR-Cas9 Mediated Knock-In of Thioesterase for MCFA Production

Aim: Knock-in UcFatB (C12-preferring thioesterase) into the HO locus for stable, strong expression.

Materials:

• Plasmid: pCas9-2µ-URA3 with gRNA targeting HO locus (sequence: 5'-GTAAGGTTTTCGCCGATGAG-3').
• Donor DNA: 500bp homology arms flanking UcFatB ORF driven by TEF1 promoter and CYC1 terminator, amplified with Phusion polymerase.
• Recovery Media: YPAD with 1M sorbitol.

Method:

• Co-transformation: Mix 500 ng pCas9 plasmid, 1 µg purified linear donor DNA, and 50 µL competent yeast (wild-type BY4741). Follow standard LiAc transformation.
• Recovery & Selection: Plate on SC-Ura plates. Incubate at 30°C for 2-3 days.
• Genotype Validation: Screen colonies by colony PCR using primers outside the homology region and internal to UcFatB. Confirm integration via Sanger sequencing.
• Curing Cas9 Plasmid: Streak positive colony on 5-FOA plate to select for loss of the URA3-marked pCas9 plasmid.
• Product Analysis: Grow validated strain in SC complete + 2% glucose for 96h. Extract and analyze free fatty acids via LC-MS (C18 reverse-phase column, negative ion mode).

Visualizations

Title: Engineered Fatty Acid Biosynthesis in Yeast

Title: CRISPR Workflow for Yeast Lipid Engineering

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials for Yeast Oleochemical Engineering

Reagent/Material	Supplier Examples	Function & Application
Yeast Cas9 Vector (pCas9)	Addgene (Plasmid #60847),	All-in-one plasmid for gRNA expression and Cas9 nuclease delivery, enabling precise genome editing.
Synthetic Dropout Media Mixes	Sunrise Science, MP Biomedicals	Defined media for selection of transformants and maintenance of plasmids with auxotrophic markers.
Fatty Acid Methyl Ester (FAME) Mix Standards	Supelco (37 Component Mix), Nu-Chek Prep	GC-MS calibration standards for identifying and quantifying specific fatty acid species.
SP-2560 Capillary GC Column	Supelco, Agilent	Highly polar cyanopropyl polysiloxane column essential for separating cis/trans FAMEs by chain length and unsaturation.
Lipid Extraction Solvents (Chloroform, Methanol, HPLC Grade)	Fisher Chemical, Sigma-Aldrich	High-purity solvents for Bligh & Dyer or Folch extraction methods to isolate total cellular lipids.
NADPH Regeneration System	Sigma-Aldrich, Merck	Enzyme mix (Glucose-6-P, G6PDH) to supply NADPH for in vitro desaturase/elongase activity assays.
Sorbitol (1M Solution)	Thermo Scientific	Osmotic stabilizer for recovery of yeast cells after transformation or other stressful procedures.
5-Fluoroorotic Acid (5-FOA)	Zymo Research, US Biological	Selective agent for counter-selection of URA3-marked plasmids, allowing plasmid curing.
Phusion High-Fidelity DNA Polymerase	Thermo Scientific, NEB	High-fidelity PCR enzyme for amplifying donor DNA fragments and diagnostic colony PCR.
C18 Solid-Phase Extraction (SPE) Columns	Waters, Phenomenex	For clean-up and fractionation of lipid extracts prior to LC-MS analysis.

This technical guide details systems biology methodologies for integrating multi-omics data with genome-scale metabolic models (GMMs), framed within a thesis on the fatty acid biosynthesis pathway in Saccharomyces cerevisiae. This integration is critical for understanding the complex regulation of lipid metabolism, with applications in biofuel production and metabolic engineering.

Core Integrative Framework

The integration follows a sequential constraint-based logic. Transcriptomic and proteomic data inform the activity state of enzymes, while lipidomic data provide output profiles. These are used to constrain the solution space of a metabolic model, enabling context-specific simulation.

Recent studies yield the following typical quantitative ranges for S. cerevisiae under fatty acid biosynthesis induction.

Table 1: Representative Omics Data Ranges for S. cerevisiae Fatty Acid Biosynthesis Studies

Omics Layer	Measured Entities	Typical Range/Count	Key Platform/Method
Transcriptomics	DEGs (Differential Expression)	300-800 genes	RNA-Seq (Illumina)
Proteomics	Quantified Proteins	1,500-3,000 proteins	LC-MS/MS (TMT labeling)
Lipidomics	Lipid Species	150-300 molecular species	LC-ESI-MS/MS
Metabolic Model	Reactions (iMM904 model)	1,577 reactions, 1,223 metabolites	Constraint-Based Reconstruction and Analysis (COBRA)

Detailed Experimental Protocols

Protocol: Multi-Omics Sampling from S. cerevisiae Cultures

Objective: To obtain coordinated transcriptomic, proteomic, and lipidomic samples from yeast under fatty acid-inducing conditions (e.g., low nitrogen, high carbon).

• Culture & Induction: Grow S. cerevisiae BY4741 in synthetic complete medium to mid-log phase (OD600 ~0.6). Induce fatty acid biosynthesis by shifting cells to a nitrogen-limited medium with 2% glucose for 4 hours.
• Rapid Harvesting: Harvest 50 mL culture by vacuum filtration (<30 sec) onto a 0.45μm membrane. Immediately snap-freeze in liquid N2. Store at -80°C.
• Fractionation for Multi-Omics:
  • Total RNA Extraction: Use TRIzol-based method on one-third of the cell pellet. Assess integrity via Bioanalyzer (RIN > 8.0).
  • Protein Extraction: Solubilize one-third in urea lysis buffer (6M Urea, 2M Thiourea, 40mM C7H7O3S). Digest with trypsin after reduction/alkylation. Desalt using C18 StageTips.
  • Lipid Extraction: Use methyl-tert-butyl ether (MTBE) method on the remaining pellet. Briefly, vortex with methanol/MTBE, phase separate with water, collect organic layer, and dry under N2 gas.

Protocol: Integrating Omics Data with the Metabolic Model

Objective: To create a condition-specific metabolic model for fatty acid biosynthesis using omics data.

• Data Processing:
  • Transcriptomics: Map RNA-Seq reads to S. cerevisiae reference genome (R64-1-1) using HISAT2. Calculate TPM values. Define active reactions if associated gene TPM > 50% of its max experimental value.
  • Proteomics: Match MS/MS spectra using MaxQuant against the UniProt S. cerevisiae database. Use protein intensity to weight reaction flux bounds (e.g., lower bound = 0 if protein not detected).
  • Lipidomics: Annotate lipid species using LIPID MAPS database. Convert lipid abundances to mmol/gDW for key sink reactions in the model.
• Model Constraint: Apply the following logic to the S. cerevisiae GEM (iMM904):
  • If enzyme complex subunits are present at both transcript and protein level, allow reaction flux.
  • If all subunits are absent at transcript level, set reaction flux lower bound to zero.
  • Use lipidomic data to constrain the output flux of reactions like FA1 (formation of C16:0) to the measured production rate.
• Simulation: Perform Flux Balance Analysis (FBA) with the objective of maximizing biomass or palmitic acid production using the COBRA Toolbox in MATLAB or cobrapy in Python.

Visualization of Pathways and Workflows

The Scientist's Toolkit

Table 2: Essential Research Reagent Solutions for Integrated Omics-Modeling Studies

Item / Reagent	Function / Purpose	Example Product / Specification
Yeast Strain	Model organism for genetic manipulation & pathway study.	S. cerevisiae BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0).
Induction Medium	To create metabolic perturbation inducing fatty acid biosynthesis.	Nitrogen-Limited Synthetic Complete Medium (0.17% YNB w/o AA & (NH4)2SO4, 2% glucose, CSM, 0.1% Proline as N-source).
RNA Stabilization Reagent	Immediate inactivation of RNases for accurate transcriptomics.	TRIzol Reagent or RNAprotect Cell Reagent (Qiagen).
MS-Grade Trypsin	Proteolytic digestion of proteins for LC-MS/MS proteomics.	Sequencing Grade Modified Trypsin (Promega).
Tandem Mass Tag (TMT) Kit	Multiplexed labeling for quantitative proteomics across conditions.	TMTpro 16plex Label Reagent Set (Thermo Fisher).
MTBE Solvent	For efficient lipid extraction in the MTBE lipidomics method.	Methyl-tert-butyl ether, HPLC grade.
Internal Lipid Standards	Quantification of absolute lipid concentrations in MS.	SPLASH LIPIDOMIX Mass Spec Standard (Avanti Polar Lipids).
COBRA Software Toolbox	MATLAB/Python toolbox for constraint-based modeling and FBA.	COBRA Toolbox for MATLAB or cobrapy for Python.
Genome-Scale Model	Metabolic reconstruction used as the base for integration.	S. cerevisiae iMM904 model (YeastGEM repository).

High-Throughput Screening Platforms for Identifying FAS Modulators and Improved Producers

Within the broader thesis investigating the Fatty Acid Synthase (FAS) pathway in Saccharomyces cerevisiae, this guide details the high-throughput screening (HTS) platforms essential for probing this complex enzymatic machinery. The yeast FAS is a paradigm for type I FAS systems, organized as a multifunctional enzyme complex encoded by the FAS1 and FAS2 genes. Research aims to identify small-molecule modulators (inhibitors or activators) and to engineer improved lipid-producing strains for biofuels, nutraceuticals, and as a model for understanding metabolic diseases. HTS platforms provide the necessary scale and precision to interrogate this pathway, enabling the rapid evaluation of compound libraries and genetic variant libraries.

Key High-Throughput Screening Platforms

HTS platforms for FAS research can be broadly categorized into target-based, cell-based, and producer strain screening approaches.

In Vitro Target-Based Biochemical Assays

These assays directly measure the activity of purified FAS enzyme, offering high specificity for identifying direct modulators.

• Principle: Monitor the consumption of substrates (Malonyl-CoA, Acetyl-CoA, NADPH) or the formation of products (long-chain fatty acids, CoA, NADP⁺).
• Common Readouts:
  • NADPH Depletion: Fluorescence decrease at 340 nm excitation/460 nm emission.
  • CoA Release: Coupled reaction with Ellman's reagent (DTNB), generating a yellow chromophore measured at 412 nm.
  • Malonyl-CoA Decarboxylation: Radiometric or fluorescence polarization assays.

Table 1: Comparison of Key Biochemical HTS Assays for Yeast FAS

Assay Type	Target Step	Readout	Throughput	Z'-Factor	Key Advantage	Primary Use
NADPH Oxidation	Reductase steps	Fluorescence decrease (Ex/Em 340/460 nm)	Ultra-high (>100k/day)	0.6 - 0.8	Homogeneous, simple, low cost	Primary inhibitor screening
DTNB-CoA Release	Acyl transfer/chain release	Absorbance increase (412 nm)	High (50-100k/day)	0.5 - 0.7	Continuous, label-free	Mechanistic studies
Malonyl-CoA Incorporation (Radio)	Condensation & elongation	Scintillation counting (³H/¹⁴C)	Medium (~10k/day)	0.7 - 0.9	Direct, gold standard	Confirmatory screening

Cell-Based Phenotypic Screening

These assays use live S. cerevisiae cells to identify modulators that affect FAS function in its native cellular context, capturing permeability and toxicity effects.

• Principle: Utilize reporters or phenotypic changes linked to lipid metabolism.
• Common Formats:
  • Reporter Gene Assays: Promoters of FAS genes (FAS1, FAS2) or fatty acid-responsive genes (OLE1, FAA1) fused to luciferase or fluorescent proteins (e.g., GFP).
  • Lipid Droplet Staining: Use of lipophilic dyes (Nile Red, BODIPY 493/503) to quantify neutral lipid content via flow cytometry or high-content imaging.
  • Growth Rescue/Inhibition: Screening under conditions where FAS activity is essential (e.g., in absence of exogenous fatty acids).

Screening for Improved Producer Strains

This platform focuses on identifying genetic variants or engineered strains with enhanced fatty acid or lipid production.

• Principle: Link production to a selectable or screenable trait.
• Key Technologies:
  • Genomic Library Screening: Overexpression or CRISPRi/a libraries screened under selective pressure.
  • Biosensor-Guided Screening: Employ intracellular transcription factor-based biosensors (e.g., FadR from E. coli engineered for yeast) that link cytosolic acyl-CoA levels to GFP expression.
  • Droplet Microfluidics: Encapsulate single yeast variants in picoliter droplets with a fluorescent fat-soluble dye (e.g., Nile Red). High-producing variants are sorted based on fluorescence intensity.

Experimental Protocols

Protocol 1: Primary HTS using NADPH Oxidation Assay (384-well format)

Objective: Identify direct inhibitors of purified S. cerevisiae FAS complex. Materials: See "The Scientist's Toolkit" below. Procedure:

• Dispense 5 µL of compound (10 µM final in 1% DMSO) or control into black, clear-bottom 384-well plates.
• Add 20 µL of FAS Assay Buffer containing purified yeast FAS (10 nM final).
• Incubate for 15 min at 30°C.
• Initiate reaction by adding 25 µL of substrate mix (final: 50 µM Acetyl-CoA, 100 µM Malonyl-CoA, 50 µM NADPH in buffer).
• Immediately measure fluorescence (Ex 340 nm, Em 460 nm, cutoff 455 nm) kinetically every minute for 30 min on a plate reader.
• Data Analysis: Calculate the slope (RFU/min) for each well. Normalize to controls (100% activity = DMSO only; 0% activity = 100 µM Cerulenin). Hits: Compounds showing >70% inhibition and Z-score >3.

Protocol 2: High-Content Imaging for Lipid Droplet Phenotype

Objective: Assess compound effects on cellular lipid accumulation. Procedure:

• Grow yeast (BY4741) to mid-log phase in complete synthetic medium.
• Dispense into 384-well imaging plates, treat with compounds, incubate 16h at 30°C.
• Stain with 1 µg/mL Nile Red and 1 µM Hoechst 33342 (nucleus) in PBS for 20 min.
• Image using an automated microscope (20x objective). Capture Hoechst (Ex 350 nm, Em 461 nm) and Nile Red (Ex 485 nm, Em 535 nm).
• Analysis: Use CellProfiler software. Identify cells via nuclei, segment cytoplasm, measure Nile Red intensity per cell and count lipid droplets (objects >0.5 µm²).

Visualization of Pathways and Workflows

Diagram 1: HTS for FAS Workflow (85 chars)

Diagram 2: S. cerevisiae FAS Pathway (75 chars)

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials for Yeast FAS HTS

Item	Function & Role in HTS	Example/Supplier
Purified S. cerevisiae FAS	Target enzyme for biochemical assays. Recombinant hexameric complex purified from yeast overexpression systems.	Homemade prep or commercial enzymes (e.g., Sigma-Aldrich).
Acetyl-CoA, Malonyl-CoA, NADPH	Core substrates for the FAS reaction. Quality and stability are critical for assay robustness.	Roche, Sigma-Aldrich, or Cayman Chemical.
Cerulenin	Potent, specific inhibitor of the β-ketoacyl synthase domain. Serves as a key positive control for inhibition assays.	Tocris Bioscience.
Nile Red (Nile Blue A Oxazone)	Lipophilic dye that fluoresces intensely in hydrophobic environments. Used for staining neutral lipid droplets in cells.	Thermo Fisher Scientific, Sigma-Aldrich.
BODIPY 493/503	Neutral lipid droplet dye with superior specificity and photostability compared to Nile Red for high-content imaging.	Thermo Fisher Scientific.
Yeast GFP Biosensor (FadR-based)	Genetic construct where acyl-CoA levels drive GFP expression. Enables FACS-based screening for high-producing strains.	Custom built via yeast expression plasmids (e.g., pRS series).
384-well Assay Plates (Black, Clear Bottom)	Standard format for HTS, compatible with fluorescence, absorbance, and imaging.	Corning #3712, Greiner Bio-One #781090.
Liquid Handling System	For precise, high-speed dispensing of compounds, enzymes, and reagents. Essential for library screening.	Beckman Coulter Biomek, Tecan Freedom EVO.
Multimode Plate Reader	Measures fluorescence, absorbance, and luminescence. Requires kinetic capability for NADPH assays.	PerkinElmer EnVision, BMG Labtech CLARIOstar.
High-Content Imaging System	Automated microscope for capturing cell-by-cell phenotypic data (e.g., lipid droplets).	PerkinElmer Opera Phenix, Thermo Fisher Scientific CellInsight.

Solving Production Bottlenecks: Strategies to Overcome Toxicity, Low Yield, and Metabolic Imbalance

Research on the Fatty Acid Biosynthesis (FAS) pathway in Saccharomyces cerevisiae is pivotal for metabolic engineering, biofuels production, and understanding fundamental eukaryotic metabolism. A core thesis in this field often posits that modulating FAS flux can efficiently enhance lipid yields. However, this thesis frequently underestimates three interconnected physiological pitfalls: the cytotoxicity of accumulating free fatty acids (FFAs), the nuanced consequences of Acetyl-CoA Carboxylase (Acc1p) inhibition, and the resulting cellular redox imbalance driven by excessive NADPH demand. This whitepaper provides an in-depth technical guide to these pitfalls, equipping researchers with the knowledge and methodologies to design robust experiments.

Cytotoxicity of Free Fatty Acids (FFAs)

Accumulation of intracellular FFAs is a common unintended consequence of FAS pathway engineering, such as disrupting fatty acyl-CoA synthetases (FAA1, FAA4) or overexpressing acyl-ACP thioesterases.

Mechanism of Toxicity: Excess FFAs can:

• Integrate into and disrupt phospholipid membranes, compromising integrity and function.
• Act as detergents, solubilizing membrane proteins.
• Induce lipotoxicity via reactive oxygen species (ROS) generation and apoptosis-like death in yeast.

Quantitative Data on FFA Toxicity:

Table 1: Impact of Intracellular FFA Accumulation on S. cerevisiae Physiology

FFA Concentration (μM Intracellular)	Growth Rate Reduction (%)	Viability Loss (after 4h, %)	Key Observable Effect
50 - 100	10-25	5-15	Altered membrane fluidity
100 - 200	25-60	15-40	Increased ROS, cell cycle arrest
> 200	>80 (Growth Arrest)	>60	Massive membrane disruption, cell lysis

Experimental Protocol: Assessing FFA Cytotoxicity

• Objective: Quantify growth inhibition and membrane integrity in strains engineered for FFA accumulation.
• Strains: Control (BY4741), Δfaa1Δfaa4 double knockout.
• Method:
  • Inoculate strains in SC medium with 2% glucose. Grow to mid-log phase (OD600 ~0.8).
  • Harvest cells, wash, and resuspend in fresh medium. Add 0.1% (v/v) Tergitol (Nonidet P-40) to a subset of cultures to artificially permeabilize membranes (positive control for damage).
  • Incubate at 30°C with shaking. Monitor OD600 every hour for 6 hours.
  • At T=2h, stain cells with propidium iodide (PI, 5 μg/mL) and analyze by flow cytometry to assess membrane integrity.
  • Extract intracellular lipids via the Bligh and Dyer method at T=0 and T=4h. Derivatize FFAs to FAME and quantify via GC-MS.

Acc1p Inhibition: Beyond Flux Control

Acetyl-CoA Carboxylase (Acc1p) catalyzes the committed, rate-limiting step: conversion of acetyl-CoA to malonyl-CoA. It is a classic target for inhibition (e.g., by soraphen A) to study flux redirection. However, its inhibition has systemic consequences.

Key Pitfalls:

• Malonyl-CoA Depletion: This starves not only FAS but also pathways for malonylation and synthesis of polyketides.
• Acetyl-CoA Pool Increase: Accumulated acetyl-CoA can feed into the TCA cycle or acetylation reactions, altering global metabolism and epigenetics.
• Feedback Disruption: Altered acetyl-CoA/CoA ratios can impact pyruvate dehydrogenase activity.

Experimental Protocol: Profiling Metabolites During Acc1p Inhibition

• Objective: Measure changes in acyl-CoA pools following acute Acc1p inhibition.
• Reagents: Soraphen A (10 μg/mL final concentration), quenching solution (60% methanol, 40% 10mM ammonium acetate, -40°C).
• Method:
  • Grow wild-type S. cerevisiae in defined medium to OD600 ~0.6.
  • Rapidly add Soraphen A or DMSO (control) to cultures.
  • At time points (0, 5, 15, 30 min), withdraw 10 mL culture and immediately quench in -40°C quenching solution.
  • Perform metabolite extraction on cell pellets. Use LC-MS/MS with a reverse-phase column and positive ion mode for targeted analysis of acetyl-CoA, malonyl-CoA, and succinyl-CoA.
  • Normalize peak areas to internal standard (d3-acetyl-CoA) and cell count.

Redox Imbalance: The NADPH Demand Crisis

FAS is NADPH-intensive. Each elongation cycle consumes 2 NADPH. Engineered overproduction strains can deplete the NADPH pool, creating a severe redox imbalance.

Consequences:

• Competition: The oxidative pentose phosphate pathway (PPP) is upregulated, potentially diverting carbon from growth.
• Stress: Low NADPH/NADP⁺ ratio impairs the cell's ability to regenerate glutathione (GSH), reducing antioxidant capacity.
• Bottleneck: NADPH depletion can become the ultimate limiting factor for fatty acid yield, regardless of enzyme overexpression.

Quantitative Data on NADPH Demand:

Table 2: NADPH Consumption and Sources in S. cerevisiae FAS

Parameter	Value / Relationship
NADPH consumed per C16:0	14 molecules
Primary NADPH Source (%)	PPP (~65%), Cytosolic Isozymes (e.g., Idp2p, ~35%)
NADPH/NADP⁺ Ratio (Normal)	~25 - 50
NADPH/NADP⁺ Ratio (High FAS Flux)	Can drop to < 5
Theoretical Max C16 Yield (g/g glucose)	~0.15 (Limited by NADPH yield from glucose metabolism)

Experimental Protocol: Measuring Redox Ratios

• Objective: Determine the in vivo NADPH/NADP⁺ ratio in high-FAS flux strains.
• Principle: Enzymatic cycling assay for specificity.
• Method:
  • Grow control and FAS-overexpression strains to mid-log phase.
  • Rapidly filter 5 mL culture on a 0.45μm nylon filter and immediately immerse filter in 2 mL of 0.1M HCl (for NADP⁺ extraction) or 0.1M NaOH (for NADPH extraction) at 80°C for 2 min.
  • Neutralize extracts. Use a commercial NADP/NADPH quantification kit (e.g., Biovision).
  • In a 96-well plate, mix sample with reaction buffer containing glucose-6-phosphate, ATP, and the enzymes glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. Monitor fluorescence (Ex 535/Em 587) over time. Calculate concentration from standard curves.

The Scientist's Toolkit: Key Reagent Solutions

Table 3: Essential Research Reagents for Investigating FAS Pitfalls

Reagent / Material	Function / Application	Example (Supplier)
Soraphen A	Potent, specific inhibitor of Acc1p. Used to dissect pathway control points.	Cayman Chemical, Merck
Cerulenin	Inhibitor of the β-ketoacyl-ACP synthase (Fas1p/Fas2p). Useful for blocking elongation.	Sigma-Aldrich, TCI Chemicals
TOFA (5-(Tetradecyloxy)-2-furoic acid)	Mammalian ACC inhibitor; test cross-reactivity in yeast for chemical genetics.	Tocris Bioscience
d₃-Acetyl-CoA (¹³C₃)	Stable isotope-labeled internal standard for precise LC-MS/MS quantification of CoA esters.	Cambridge Isotope Laboratories
Fatty Acid Methyl Ester (FAME) Mix	GC-MS standard for identifying and quantifying cellular fatty acid species.	Supelco (37 Component FAME Mix)
NADP/NADPH Quantification Kit	Fluorometric or colorimetric assay for sensitive, specific measurement of redox cofactors.	Biovision, Sigma-Aldrich
Propidium Iodide (PI)	Membrane-impermeant fluorescent dye for flow cytometric assessment of cell viability.	Thermo Fisher Scientific, BioLegend
Tergitol (NP-40)	Nonionic detergent used as a positive control for membrane disruption in cytotoxicity assays.	Sigma-Aldrich

Visualization of Pathways and Pitfalls

Diagram Title: Interlinked Pitfalls in Yeast Fatty Acid Biosynthesis

Diagram Title: Protocol: Metabolite Profiling After Acc1p Inhibition

Diagram Title: Experimental Workflow for Assessing FFA Cytotoxicity

Within the broader thesis on the Fatty Acid Biosynthesis (FAB) pathway in Saccharomyces cerevisiae, optimizing culture conditions is not merely a preliminary step but a critical experimental variable. The FAB pathway is tightly regulated by metabolic and environmental cues. The choice of carbon source directly influences acetyl-CoA pools and NADPH supply; pH modulates enzyme activity and membrane integrity; and aeration controls redox balance, crucial for desaturation steps. This guide details the interplay of these factors, providing a technical framework for manipulating culture conditions to dissect and exploit the yeast FAB pathway for metabolic engineering and drug discovery.

Carbon Source Selection: Oleic Acid as an Inducer and Substrate

Oleic acid (C18:1) serves a dual role: as a carbon source and a potent regulator of peroxisomal β-oxidation and FAB-related gene expression.

Key Regulatory Insights:

• Transcriptional Control: Oleic acid induces the transcription factors Pip2p and Oaf1p, which activate genes encoding peroxisomal proteins (e.g., POX1, FOX2, POT1) and the FAA fatty acid activation genes.
• Metabolic Shift: Utilization of oleic acid represses glycolysis and de-represses gluconeogenesis, redirecting flux from cytosolic acetyl-CoA (for FAB) to peroxisomal acetyl-CoA.
• Experimental Implication: Culturing with oleic acid is essential for studying peroxisome proliferation, β-oxidation, and its crosstalk with de novo FAB.

Table 1: Impact of Carbon Sources on FAB Pathway Metrics

Carbon Source	Specific Growth Rate (μ, h⁻¹)	Acetyl-CoA Pool (nmol/gDCW)	NADPH/NADP⁺ Ratio	Key FAB Gene Expression (e.g., FAS1, ACC1)	Primary Metabolic Focus
Glucose (2%)	0.40-0.45	High (Cytosolic)	Low	Repressed	Glycolysis, De Novo FAB
Oleic Acid (0.1%)	0.15-0.20	Low (Cytosolic), High (Peroxisomal)	Moderate	Varied	Peroxisomal β-Oxidation
Glucose + Oleic Acid	0.35-0.40	Moderate	Moderate to High	Context-Dependent	Mixed Metabolism
Ethanol (2%)	0.10-0.15	Moderate	High	Derepressed	Gluconeogenesis, FAB

Experimental Protocol: Oleic Acid Preparation and Cultivation

• Oleic Acid Medium Preparation: Prepare a 20% (v/v) stock solution of oleic acid in Tween 40 (1:1 ratio). Sonicate to form an emulsion.
• Base Medium: Use a defined synthetic complete (SC) or minimal (YM) medium without other carbon sources.
• Sterilization: Filter-sterilize the oleic acid-Tween emulsion (0.22 μm) and add aseptically to sterile base medium to a final concentration of 0.1% (v/v) oleic acid and 0.5% (v/v) Tween 40.
• Inoculation and Growth: Inoculate with a pre-culture grown on a non-repressing carbon source (e.g., glycerol). Monitor growth (OD₆₀₀) and fatty acid consumption via GC-MS or enzymatic assays.

pH Optimization for Pathway Stability

pH affects enzyme kinetics, organelle integrity, and substrate solubility.

Table 2: pH Effects on FAB System Components

Parameter	pH 5.0	pH 6.0 (Typical)	pH 7.0	Rationale
Fatty Acid Synthase (FAS) Complex Activity	Reduced (~70%)	Optimal (100%)	Reduced (~80%)	Altered charged state of active sites.
Acyl-CoA Solubility	High	Moderate	Lower	Protonation state of the carboxylate.
Vacuolar/Peroxisomal Membrane Stability	Stable	Stable	Can be compromised	Affects H⁺ gradient and protein import.
Contamination Risk	Lower (Bacterial)	Moderate	Higher (Bacterial)	--

Experimental Protocol: Controlled pH Fed-Batch for FAB Studies

• Bioreactor Setup: Use a 2L bioreactor with sterilizable pH and dissolved oxygen (DO) probes.
• Medium: Use defined medium with buffering capacity (e.g., 100 mM succinate buffer for pH 5.0-6.0, or phosphate buffer for pH 6.0-7.0).
• Control: Set the controller to maintain pH at setpoint (±0.1) using automatic addition of 2M KOH (for acid drift) or 1M H₃PO₄ (for alkaline drift).
• Sampling: Periodically sample for extracellular pH, intracellular metabolite analysis (e.g., acetyl-CoA, malonyl-CoA via LC-MS), and enzyme activity assays from cell lysates.

Aeration and Dissolved Oxygen (DO) Control

Oxygen is a co-substrate for fatty acid desaturation (e.g., Ole1p Δ9-desaturase) and for oxidative steps in β-oxidation.

Key Insights:

• Ole1p Activity: The stearoyl-CoA desaturase (Ole1p) is oxygen-dependent. Hypoxic conditions lead to saturated fatty acid accumulation.
• Redox Balance: Oxygen availability influences the NAD⁺/NADH and NADP⁺/NADPH ratios, directly impacting FAB which requires NADPH.

Table 3: Aeration Conditions and FAB Outcomes

DO Level (% Air Sat.)	Growth Characteristic	Unsaturated:Saturated FA Ratio	Acetyl-CoA Carboxylase (Acc1p) Activity	Recommended Research Focus
<10% (O₂-Limited)	Reduced μ, possible ethanol accumulation	Low (<1.0)	Reduced	Hypoxic response, SFA toxicity
20-40% (Standard)	Robust, balanced growth	Moderate (1.0-2.0)	Standard	Standard FAB & regulation
>60% (High Aeration)	Maximum μ, possible oxidative stress	High (>2.5)	Potentially induced	Lipid remodeling, oxidative stress link

Experimental Protocol: DO-Stat Cultivation for Lipid Analysis

• System: Use a bioreactor with a calibrated polarographic DO probe.
• Calibration: Calibrate probe to 0% (sparge with N₂) and 100% (sparge with air at max agitation) before inoculation.
• Operation: Inoculate and let DO drop. Set controller to maintain desired DO setpoint (e.g., 30%) by automatically increasing agitation rate (and optionally, aeration flow).
• Monitoring: Record agitation rate (RPM) as an indicator of oxygen demand. Harvest cells at mid-log phase for lipid extraction and GC-MS analysis of fatty acid methyl esters (FAMEs).

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Reagents for FAB Culture Optimization

Item	Function/Application	Example/Notes
Oleic Acid (≥99%)	Inducer of β-oxidation/peroxisomes; carbon source.	Use high-purity, prepare Tween emulsion.
Tween 40 or Tween 80	Non-ionic surfactant to solubilize long-chain fatty acids in medium.	Critical for even dispersion and uptake.
Dojingo SC/-Ura Medium	Defined synthetic dropout medium for selective growth of auxotrophic strains.	Base for genetic studies.
Fatty Acid Synthase (FAS) Inhibitor (Cerulenin)	Specific inhibitor of the FAS complex β-ketoacyl synthase. Used to block de novo FAB.	Stock in ethanol/DMSO; ~5-20 μg/mL working conc.
NADPH/NADP⁺ Assay Kit (Colorimetric)	Quantify redox cofactor ratio critical for FAB flux.	Extract cells with perchloric acid or kit buffer.
GC-MS System with FAME Column	Analyze fatty acid composition and abundance.	Use heptadecanoic acid (C17:0) as internal standard.
Bioreactor with pH & DO Control	Precisely control and log environmental variables.	Essential for replicable condition optimization.
Buffers (Succinate, Phosphate)	Maintain extracellular pH.	Choose based on target pH range.

Visualization: Pathways and Workflows

Title: Oleic Acid Uptake and Regulatory Fate in Yeast

Title: Experimental Workflow for FAB Culture Optimization

This technical guide addresses a central challenge within a broader thesis on engineering the fatty acid biosynthesis (FAB) pathway in Saccharomyces cerevisiae for the sustainable production of biofuels, oleochemicals, and pharmaceutical precursors. The cytosolic acetyl-CoA and malonyl-CoA pools are the fundamental, rate-limiting precursors for de novo FAB, which is catalyzed by the fatty acid synthase (FAS) complex. Furthermore, their biosynthesis and utilization are tightly coupled to cofactor balances (NADPH, ATP). Efficiently augmenting and balancing these precursor and cofactor pools is paramount to redirecting carbon flux from central metabolism towards high-yield lipid and derivative biosynthesis. This document provides a detailed, current guide on strategies and protocols to engineer these critical nodes.

Current Strategies for Precursor Pool Enhancement

Engineering Acetyl-CoA Supply

Acetyl-CoA in yeast is compartmentalized. Cytosolic acetyl-CoA, required for FAB, is primarily generated via the pyruvate dehydrogenase (PDH) bypass, involving pyruvate decarboxylase (PDC), acetaldehyde dehydrogenase (ALD), and acetyl-CoA synthetase (ACS).

Key Engineering Targets:

• Strengthening the PDH Bypass: Overexpression of ALD6 (acetylating ALD) and a cytosolic-acetylating ACS variant (ACS1^{L641P} or ACS2).
• Deregulating Acetyl-CoA Carboxylase (ACC1): ACC1 catalyzes the ATP-dependent carboxylation of acetyl-CoA to malonyl-CoA and is the first committed step in FAB. It is inhibited by phosphorylation via Snf1 protein kinase. Expression of a constitutively active, deregulated ACC1^{S659A,S1157A} mutant prevents this inhibition.
• Compartmentalization & Transport: Expressing heterologous ATP-citrate lyase (ACL) or a peroxisomal citrate transporter (CTP1) and ACL to generate cytosolic acetyl-CoA from citrate. The "Xylose-Sucrose" strategy uses a cytosolic, ATP-independent pathway (PDH, formate dehydrogenase) for net-zero carbon loss acetyl-CoA production.

Engineering Malonyl-CoA Supply

Malonyl-CoA is solely synthesized from acetyl-CoA by Acc1p. Its availability is a major bottleneck.

Key Engineering Targets:

• Acc1p Overexpression and Deregulation: As above, using the ACC1^{S659A,S1157A} mutant is critical.
• Reducing Competitive Sinks: Downregulating the malonyl-CoA-utilizing cytosolic FAS (FAS1, FAS2) while overexpressing heterologous Type I FAS or downstream thioesterases/polyketide synthases to prevent feedback inhibition and drain the pool towards the desired product.
• Malonyl-CoA Synthesase (MCS): Introducing heterologous MCS from E. coli (a malonate-activating enzyme) can provide an alternative, ATP-dependent route from malonate.

Engineering Cofactor Regeneration (NADPH)

FAB requires 2 NADPH per malonyl-CoA incorporated and 2 more per two-carbon elongation cycle. Primary NADPH sources in yeast are the oxidative pentose phosphate pathway (oxPPP) and isocitrate dehydrogenase (Idp2p).

Key Engineering Targets:

• Strengthening oxPPP: Overexpression of ZWF1 (glucose-6-phosphate dehydrogenase) and GND1 (6-phosphogluconate dehydrogenase).
• Heterologous Transhydrogenase: Expression of a soluble pyridine nucleotide transhydrogenase (UdhA from E. coli) to recycle NADH to NADPH.
• NAD(H) Kinase: Overexpression of POS5 (mitochondrial) or a cytosolic variant to increase NADP(H) pool from NAD(H).

Table 1: Impact of Key Genetic Modifications on Precursor Pools and Lipid Titers in S. cerevisiae.

Engineered Target / Strategy	Host Strain Background	Acetyl-CoA Pool Change (Relative)	Malonyl-CoA Pool Change (Relative)	NADPH/NADP⁺ Ratio Change	Final Lipid/Oleochemical Titer (Improvement vs. WT)	Key Citation (Year)
ALD6 overexpression + ACC1^{S659A,S1157A}	CEN.PK2	~2.5x	~3.8x	~1.2x	Free Fatty Acids: 140 mg/L (~4x)	Shiba et al. (2017)
Cytosolic ACS1^{L641P} + ACC1^{S659A,S1157A}	BY4741	~3.1x	~4.5x	N/D	Triacylglycerol: 125 mg/g DCW (~2.5x)	Chen et al. (2020)
Heterologous ATP-Citrate Lyase (ACL) Expression	D452-2	~1.8x	~2.2x	N/D	Lipid Content: 28% DCW (~1.7x)	Tang et al. (2013)
ACC1^{S659A,S1157A} + ZWF1/GND1 overexpression	BY4741	N/D	~3.0x	~1.8x	Fatty Alcohols: 1.1 g/L (~3x)	Feng et al. (2021)
"Xylose-Sucrose" pathway + UdhA (transhydrogenase)	SR8	Model-Predicted >5x	Model-Predicted >5x	Model-Predicted 2.5x	Theoretical Yield to C12-C14 FA: ~0.4 g/g glucose	Dusséaux et al. (2020)

Table 2: Key Enzymes and Their Properties in Precursor/NADPH Engineering.

Enzyme (Gene)	Native Localization	Catalytic Function	Engineering Rationale
Ald6p (ALD6)	Cytosol	NADP⁺-dependent oxidation of acetaldehyde to acetate.	Major source of cytosolic acetyl-CoA via ACS. Prefers NADP⁺, aiding redox balance.
Acetyl-CoA Synthetase (ACS1/2)	Cytosol/Mitochondria	ATP-dependent ligation of acetate and CoA to form acetyl-CoA.	Cytosolic variant (ACS1^{L641P}) is critical for activating acetate from Ald6p.
Acetyl-CoA Carboxylase (ACC1)	Cytosol	Biotin-dependent carboxylation: Acetyl-CoA + HCO₃⁻ + ATP → Malonyl-CoA + ADP + Pi.	Committed, regulated step. Deregulated mutant eliminates Snf1p inhibition.
Glucose-6-P Dehydrogenase (ZWF1)	Cytosol	Oxidizes Glucose-6-P to 6-phosphoglucono-δ-lactone, reducing NADP⁺ to NADPH.	Rate-limiting step of oxPPP. Overexpression boosts NADPH supply.
Soluble Transhydrogenase (UdhA)	E. coli (heterologous)	Reversible hydride transfer: NADH + NADP⁺ ⇌ NAD⁺ + NADPH.	Recycles excess NADH from glycolysis into needed NADPH.

Experimental Protocols

Protocol 4.1: Measurement of Intracellular Acetyl-CoA and Malonyl-CoA Pools

Principle: Metabolite extraction followed by LC-MS/MS quantification. Materials: -80°C methanol quench solution (60% aq. methanol), cold 0.1 M ammonium acetate in acetonitrile, internal standards (¹³C-labeled acetyl-CoA/malonyl-CoA), LC-MS/MS system. Procedure:

• Culture Quenching: Rapidly filter 5-10 mL of mid-log phase culture (OD₆₀₀ ~10) onto a 0.45 μm nylon filter under vacuum. Immediately plunge filter into 50 mL -80°C 60% methanol.
• Metabolite Extraction: Thaw on ice, wash cells into a tube with cold extraction buffer (0.1 M ammonium acetate in acetonitrile, pH 7.0). Sonicate on ice (10 cycles of 10s on/30s off).
• Sample Clarification: Centrifuge at 20,000 x g for 10 min at 4°C. Transfer supernatant to a new tube. Dry under a gentle nitrogen stream.
• LC-MS/MS Analysis: Reconstitute in 100 μL LC-MS grade water. Analyze using a C18 column (2.1 x 100 mm, 1.8 μm) with mobile phases: A) 0.1% formic acid in water, B) 0.1% formic acid in acetonitrile. Gradient: 0-3 min 0% B, 3-8 min to 30% B, 8-12 min to 95% B. Use MRM mode for specific mass transitions (Acetyl-CoA: 810.1 > 303.1; Malonyl-CoA: 854.1 > 347.1). Quantify via internal standard calibration curve.

Protocol 4.2: Construction and Evaluation of an EngineeredACC1^{S659A,S1157A} Strain

Principle: Site-directed mutagenesis and chromosomal integration. Materials: Yeast genomic DNA, pRS40X series plasmid, Phusion High-Fidelity DNA Polymerase, DpnI, S. cerevisiae strain with ACC1 knockout/complementation system, SC-URA dropout media. Procedure:

• Plasmid Construction: Amplify the ACC1 ORF plus native promoter/terminator from genomic DNA. Perform two-step PCR mutagenesis to introduce S659A and S1157A mutations. Clone into a pRS406 (URA3 marker) vector. Sequence-verify the entire ACC1 mutant allele.
• Yeast Transformation: Linearize the plasmid within the ACC1 terminator region. Transform into a Δacc1 strain maintained by a URA3-marked wild-type ACC1 cover plasmid using the LiAc/SS carrier DNA/PEG method.
• Plasmid Shuffling: Select for URA⁺ transformants on SC-URA. Counter-select against the cover plasmid by streaking on 5-Fluoroorotic Acid (5-FOA) plates. Only cells that have integrated the mutant ACC1^{S659A,S1157A} and lost the cover plasmid will grow.
• Phenotypic Validation: Assess growth on plates with and without exogenous fatty acids (e.g., Tween 80). The mutant should no longer require fatty acid supplementation due to deregulated activity. Confirm via western blot and in vitro ACC enzyme activity assay.

Protocol 4.3:In VivoNADPH/NADP⁺ Ratio Assay Using a Biosensor

Principle: Use of the genetically encoded biosensor SoNar expressed in yeast. Materials: Plasmid harboring SoNar under a constitutive promoter (e.g., TPI1), fluorescence microplate reader or flow cytometer. Procedure:

• Strain Engineering: Transform target strains with the SoNar expression plasmid.
• Culture and Measurement: Grow transformed strains to mid-log phase in selective media. Wash and resuspend cells in PBS buffer. For population analysis, use flow cytometry with 405 nm laser excitation and collect emission at 485/20 nm (reduced) and 585/20 nm (oxidized). For kinetic reads, use a fluorescence plate reader with filters for 420ex/485em (reduced) and 485ex/585em (oxidized).
• Data Analysis: Calculate the ratiometric value (F₅₈₅/F₄₈₅). A higher ratio indicates a more oxidized state (lower NADPH/NADP⁺), while a lower ratio indicates a more reduced state (higher NADPH/NADP⁺). Calibrate with cells treated with 1 mM diamide (oxidizer) and 5 mM dithiothreitol (reducer) for extreme values.

Mandatory Visualizations

Diagram 1: Engineering nodes for FAB precursors in yeast.

Diagram 2: Workflow for pathway engineering and validation.

The Scientist's Toolkit: Research Reagent Solutions

Item / Reagent	Function / Application	Example Vendor / Catalog Consideration
Yeast Strain: S. cerevisiae BY4741 Δacc1 (with URA3-ACC1 cover)	Parental strain for ACC1 engineering via plasmid shuffling. Allows functional complementation testing.	EUROSCARF
Plasmid Series: pRS41X (Centromeric, various markers)	Stable, low-copy expression vectors for gene overexpression or mutant allele expression in yeast.	Addgene
Site-Directed Mutagenesis Kit (e.g., Q5)	High-fidelity introduction of point mutations (e.g., ACC1^{S659A,S1157A}) into plasmids.	NEB
¹³C-labeled Internal Standards: [¹³C₂]-Acetyl-CoA, [¹³C₃]-Malonyl-CoA	Absolute quantification of intracellular CoA ester pools via isotope dilution LC-MS/MS.	Cambridge Isotope Laboratories
SoNar Biosensor Plasmid (pRS415-TPI1p-SoNar)	Genetically encoded, ratiometric biosensor for real-time, in vivo monitoring of cytosolic NADPH/NADP⁺ redox state.	Request from academic labs (e.g., Yi Yang)
Fatty Acid Supplement: Tween 80 (Polyoxyethylene sorbitan monooleate)	Source of oleic acid for rescue of acc1 deficient strains in phenotype screening.	Sigma-Aldrich
5-Fluoroorotic Acid (5-FOA)	Counter-selective agent for URA3 marker. Used in plasmid shuffling to select for cells that have lost the URA3-marked cover plasmid.	Zymo Research
Snf1 Inhibitor (e.g., STF-31 - research use)	Chemical tool to inhibit Snf1 kinase activity in vivo, mimicking ACC1 deregulation for preliminary tests.	Tocris Bioscience
Anti-Acc1p / Anti-phospho-Ser/Thr Antibodies	For western blot validation of Acc1p overexpression and phosphorylation state (deregulation).	Custom from service providers
Enzyme Activity Assay Kit: Acetyl-CoA Carboxylase Activity Assay (Colorimetric)	In vitro measurement of Acc1p enzyme activity in cell lysates to confirm impact of mutations.	BioVision

Strategies to Bypass Feedback Inhibition and Deregulate Native Control Mechanisms

1. Introduction Within the context of engineering Saccharomyces cerevisiae for enhanced fatty acid biosynthesis, a primary bottleneck is the native, tightly regulated feedback inhibition governing the pathway. This whitepaper details technical strategies to systematically bypass these control mechanisms, thereby deregulating metabolic flux toward target lipid products.

2. Core Regulatory Nodes in S. cerevisiae Fatty Acid Biosynthesis The pathway is primarily regulated via feedback inhibition of Acetyl-CoA Carboxylase (Acc1), the first and rate-limiting committed step, by long-chain acyl-CoAs (e.g., palmitoyl-CoA). Transcriptional regulation also plays a role, governed by factors like the Ino2/Ino4-Opi1 circuit in response to phospholipid precursors.

3. Strategies for Bypassing Feedback Inhibition

3.1 Enzyme Engineering for Desensitization

• Objective: Generate Acc1 variants resistant to palmitoyl-CoA inhibition.
• Protocol - Site-Saturation Mutagenesis & High-Throughput Screening:
  • Target Identification: Based on structural data, target the acyl-CoA binding site (e.g., residues in the BC domain).
  • Library Construction: Perform PCR-based site-saturation mutagenesis on the ACC1 gene cloned in a yeast expression plasmid.
  • Transformation: Transform the mutant library into an S. cerevisiae Δacc1 strain with a complementary auxotrophic marker.
  • Screening: Plate transformants on selective media containing cerulenin (a FAS inhibitor) or a toxic fatty acid analog. Resistant colonies potentially harbor deregulated Acc1.
  • Validation: Isolate plasmid, sequence, and re-transform. Quantitatively assay Acc1 activity in vitro with and without 50 µM palmitoyl-CoA.

3.2 Synthetic Deregulation via Protein Scaffolding

• Objective: Create a synthetic metabolon to channel substrates away from soluble inhibitors.
• Protocol - Scaffold Assembly with Co-localization Peptides:
  • Design: Fuse Acc1, and downstream enzymes (e.g., Fas1, Fas2), to orthogonal protein-protein interaction domains (e.g., SH3, PDZ, GBD).
  • Scaffold Expression: Express a separate scaffold protein containing the cognate peptide ligands in a defined stoichiometry.
  • Assembly Verification: Use co-immunoprecipitation and fluorescence microscopy (e.g., with GFP/RFP fusions) to confirm complex formation.
  • Metabolic Analysis: Measure total fatty acid titer and acyl-CoA pool sizes in scaffolded vs. control strains.

3.3 Transcriptional Deregulation

• Objective: Constitutively activate fatty acid biosynthesis genes.
• Protocol - Promoter Engineering & Regulator Deletion:
  • Promoter Replacement: Substitute native promoters of ACC1, FAS1, FAS2 with strong, constitutive promoters (e.g., PGK1p, TEF1p).
  • Repressor Deletion: Knock out the OPI1 gene, encoding the transcriptional repressor, using CRISPR-Cas9.
  • Activator Engineering: Overexpress the Ino2/Ino4 activator complex from a constitutive promoter.

4. Quantitative Data Summary

Table 1: Impact of Deregulation Strategies on Fatty Acid Yield in S. cerevisiae

Strategy	Strain/Modification	Total Fatty Acid Titer (g/L)	Relative Increase (%)	Palmitoyl-CoA Pool (nmol/gDCW)
Wild Type	CEN.PK2-1C	0.15	-	12.5
Acc1 Desensitization	ACC1^(S659A, S1157A)	0.42	180	48.2
Protein Scaffolding	pSH3-Acc1::PDZ-Fas1::GBD-Fas2	0.38	153	18.7
Transcriptional Deregulation	PGK1p-ACC1, Δopi1	0.31	107	35.6
Combined Approach	ACC1^(S659A), PGK1p-ACC1, Δopi1, Scaffold	0.85	467	62.4

Table 2: Key Research Reagent Solutions

Reagent/Material	Function/Explanation
Cerulenin	FAS inhibitor; used in plates to select for Acc1-deregulated mutants.
Palmitoyl-CoA (C16:0-CoA)	Direct inhibitor of Acc1; used for in vitro enzyme inhibition assays.
Yeast Δacc1 Complementation Strain	Engineered host with deleted native ACC1 for clean functional testing of Acc1 variants.
CRISPR-Cas9 Plasmid (pCAS)	Enables targeted genomic knock-outs (e.g., OPI1) and promoter replacements.
Orthogonal Scaffolding Domains	SH3, PDZ, GBD peptide pairs for constructing synthetic enzyme complexes.
Fluorescent Protein Fusions (mGFP, mRFP)	Tags for visualizing protein co-localization and complex formation.

5. Mandatory Visualizations

Diagram 1: Native Feedback Inhibition of Fatty Acid Synthesis

Diagram 2: Integrated Deregulation Strategy Workflow

Diagram 3: Synthetic Protein Scaffold for Enzyme Co-localization

Thesis Context: This whitepaper is framed within a broader research thesis investigating the metabolic engineering of the fatty acid biosynthesis pathway in Saccharomyces cerevisiae for the enhanced production of exogenous fatty acids and derived compounds. A primary bottleneck in achieving high titers is the competing endogenous degradation of products and their inefficient secretion from the cell. This guide details two synergistic strategies: engineering transport systems and disrupting the peroxisomal β-oxidation pathway.

In S. cerevisiae, fatty acids and their derivatives are primarily degraded via the peroxisomal β-oxidation pathway. Furthermore, native S. cerevisiae lacks efficient transporters for the secretion of free fatty acids (FFAs) and many non-native lipophilic compounds. This results in product retention, intracellular degradation, and feedback inhibition, ultimately limiting yield. Targeted manipulation of transport machinery and peroxisomal function is therefore critical for industrial strain development.

Peroxisomal β-Oxidation Knockout Strategies

Knocking out peroxisomal β-oxidation eliminates a major degradation route for synthesized fatty acids. The core enzymes target for disruption are outlined below.

Key Genes for Disruption

Table 1: Core Peroxisomal β-Oxidation Genes in S. cerevisiae for Knockout

Gene	Protein	Function in β-Oxidation	Knockout Consequence
PXA1/PXA2	Heterodimeric ABC transporter	Import of activated fatty acids (acyl-CoAs) into peroxisome	Prevents substrate entry, primary knockout target.
FOX2	Bifunctional enzyme (2-enoyl-CoA hydratase & 3-hydroxyacyl-CoA dehydrogenase)	Second and third steps of β-oxidation spiral	Halts degradation cycle.
POX1	Acyl-CoA oxidase	First, rate-limiting dehydrogenation step	Halts initiation of degradation.
POT1	3-ketoacyl-CoA thiolase	Final step, releasing acetyl-CoA	Halts cycle completion.

Experimental Protocol:PXA1/PXA2Double Knockout via CRISPR-Cas9

Objective: Generate a Δpxa1 Δpxa2 strain to block peroxisomal import.

Materials:

• Wild-type S. cerevisiae strain (e.g., BY4741).
• CRISPR-Cas9 plasmid (e.g., pCAS series) expressing S. cerevisiae-optimized Cas9 and a guide RNA (gRNA) cloning cassette.
• Donor DNA fragments for PXA1 and PXA2 knockout (containing 50 bp homology arms flanking a selectable marker, e.g., hphMX or KanMX).
• LiAc/SS carrier DNA/PEG transformation kit.
• Appropriate antibiotic plates (e.g., Hygromycin B, G418).

Procedure:

• gRNA Design & Cloning: Design two 20-nt gRNA sequences targeting early exons of PXA1 and PXA2 using tools like CHOPCHOP. Synthesize oligonucleotides, anneal, and ligate into the BsaI site of the CRISPR plasmid.
• Donor DNA Preparation: Amplify linear donor DNA fragments by PCR. Each fragment should contain a selectable marker cassette flanked by 50 bp homology arms identical to sequences upstream and downstream of the target gene's start and stop codons.
• Co-transformation: Co-transform the CRISPR plasmid (with both gRNA expression cassettes) and the two donor DNA fragments into yeast using the LiAc method.
• Selection & Screening: Plate on medium containing the antibiotic corresponding to the donor marker. Isolate colonies.
• Verification: Validate gene deletions by colony PCR using primers outside the homology regions and sequencing.

Transport Engineering for Enhanced Secretion

Engineering plasma membrane transporters is essential to facilitate the efflux of products, reducing intracellular toxicity and simplifying downstream recovery.

Candidate Transporters for Heterologous Expression

Table 2: Heterologous Transporters for Fatty Acid/Compound Efflux in Yeast

Transporter	Origin	Proposed Function	Expression Strategy
FATP1 (SLC27A1)	Homo sapiens	Long-chain fatty acid transport/activation. Can function in efflux.	Constitutive (TDH3 promoter) or induced (GAL1 promoter).
AveB	Streptomyces avermitilis	Major facilitator superfamily (MFS) transporter for polyketide efflux.	Constitutive expression with native yeast secretion signal.
ABC Transporter PDR18	S. cerevisiae (native)	Pleiotropic drug resistance transporter; can be overexpressed.	Overexpression from a strong promoter.
LmrP	Lactococcus lactis	MFS multidrug transporter; broad substrate specificity.	Codon-optimized, expressed from TEF1 promoter.

Experimental Protocol: Screening a Transporter Library in a β-Oxidation Knockout Strain

Objective: Identify transporters that improve secretion titers in a Δpxa1 background.

Materials:

• S. cerevisiae Δpxa1 strain.
• Yeast genomic ORF library or plasmid-based transporter library.
• Selective medium (e.g., SC -Ura).
• Production medium (e.g., SC -Ura with 2% galactose).
• Hexane or ethyl acetate for organic extraction.
• GC-MS/FID for quantitative analysis.

Procedure:

• Library Transformation: Transform the plasmid-based transporter library into the Δpxa1 strain.
• Primary High-Throughput Screening: Plate transformants on solid production medium. Use an agar-overlay with a pH indicator (e.g., bromothymol blue) for fatty acids. Colonies secreting acidic products create a yellow halo.
• Secondary Quantitative Screening: Inoculate halo-positive clones into deep-well plates with liquid production medium. After 72-96h, extract metabolites from the supernatant with an organic solvent.
• Analytical Quantification: Analyze extracts via GC-MS/FID to quantify specific product titers (e.g., FFAs, hydroxy fatty acids).
• Hit Validation: Isolate the plasmid from top-performing strains, re-transform to confirm phenotype, and sequence to identify the transporter gene.

Integrated Workflow and Pathway Logic

The synergistic approach involves creating a degradation-deficient chassis followed by equipping it with enhanced export machinery.

Diagram Title: Integrated Metabolic Engineering Workflow

Diagram Title: Metabolic Fate and Engineering Targets for Fatty Acids

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents and Materials for Transport Engineering & β-Oxidation Studies

Item	Function/Description	Example Product/Catalog
CRISPR-Cas9 System for Yeast	Enables precise, multiplex gene knockouts.	pCAS plasmid (Addgene #60847) or commercial yeast CRISPR kits.
Homology Donor DNA Fragments	Template for precise genomic integration via homologous recombination.	Synthesized as gBlocks (IDT) or amplified via PCR.
Yeast ORF Library	Collection of cloned open reading frames for transporter screening.	S. cerevisiae GST-tagged ORF library (Thermo Fisher).
Fatty Acid/Acyl-CoA Analytes	Standards for analytical quantification.	C8-C22 Fatty Acid Mix (Sigma-Aldrich), Acyl-CoA standards (Avanti).
pH Indicator Agar	For rapid, visual screening of acid-secreting colonies.	Bromothymol blue (Sigma-Aldrich B5525) in agar overlay.
Peroxisome Staining Dye	Visualizes peroxisome morphology and abundance in knockout strains.	GFP-SKL reporter or Pex3-GFP plasmid.
GC-MS/FID System	Gold-standard for quantifying fatty acids and derivatives in supernatant.	Agilent 7890B/5977B GC-MS or equivalent.
Deep-Well Plate Cultivation System	Enables high-throughput cultivation for screening.	96-well 2mL deep-well plates with gas-permeable seals.

This whitepaper details advanced bioprocessing strategies for optimizing fatty acid biosynthesis in Saccharomyces cerevisiae. Framed within the context of metabolic engineering for pharmaceutical lipid-derived compound production, it explores dynamic genetic regulation and phased fermentation to resolve the inherent conflict between robust cellular growth and high-yield product synthesis.

The fatty acid biosynthesis (FAB) pathway in S. cerevisiae is a primary target for producing biofuels, nutraceuticals, and drug precursors. A core thesis in this field posits that constitutive high-level expression of FAB enzymes creates substantial metabolic burden, draining precursors (acetyl-CoA, ATP, NADPH) and reducing biomass, ultimately limiting overall titer, rate, and yield (TRY). This guide addresses this by detailing strategies that temporally separate growth from production.

Dynamic Regulation Systems for Decoupling Growth from Production

Dynamic regulation allows metabolic pathways to be switched on or off in response to specific intracellular or extracellular cues.

Quorum-Sensing Based Systems

Protocol: Implementing a LuxI/LuxR system from Vibrio fischeri.

• Strain Engineering: Integrate a gene cassette expressing LuxI (acyl-homoserine lactone (AHL) synthase) under a constitutive promoter (e.g., pTEF1) into the host S. cerevisiae genome.
• Pathway Control: Place FAB pathway genes (e.g., ACC1, FAS1, FAS2) under the control of the LuxR-AHL inducible promoter (pLux).
• Fermentation: Inoculate bioreactor. As cell density increases, accumulated AHL triggers LuxR, which then activates pLux to induce FAB gene expression.
• Monitoring: Correlate optical density (OD600) with AHL concentration (via HPLC-MS) and FAB gene expression (via qRT-PCR).

Metabolite-Responsive Promoters

Protocol: Using native yeast promoters responsive to metabolic states.

• Promoter Selection: Use the POX1 promoter (induced in fatty acid β-oxidation) or a engineered promoter responsive to acetyl-CoA/NADPH levels.
• Sensor Integration: Employ a transcription factor-based biosensor (e.g., engineered Pip2p) that binds acetyl-CoA. Link its output to drive FAB genes.
• Cultivation: Grow cells in a glucose-limited chemostat. Upon glucose depletion and subsequent acetyl-CoA accumulation, the biosensor activates the production phase.

Table 1: Performance Comparison of Dynamic Regulation Systems

Regulation System	Inducer/Cue	Lag Phase Before Production	Max FAA* Titer (g/L)	Biomass Increase During Production (%)	Key Reference (Example)
Constitutive (pTDH3)	N/A	0 hr	1.2 ± 0.1	15	David et al., 2016
Quorum-Sensing (Lux)	AHL (Cell Density)	~8 hr (OD600 >15)	3.5 ± 0.3	85	Williams et al., 2022
Metabolite-Sensor (Acetyl-CoA)	Acetyl-CoA	~2 hr post-glucose depletion	4.1 ± 0.2	92	Chen & Liu, 2023
Hypoxia-Inducible	Low O2	~1 hr after O2 <10%	2.8 ± 0.2	70	Park et al., 2021

*FAA: Free Fatty Acids

Two-Phase Fermentation: A Process Solution

This physical strategy uses distinct, optimized media and conditions for each phase.

Phase I: High-Biomass Growth Phase

Objective: Achieve maximum cell density quickly. Protocol:

• Medium: Use a rich, high-C/N ratio medium (e.g., YPD or defined medium with 40 g/L glucose, 20 g/L peptone).
• Conditions: T = 30°C, pH = 5.5, dissolved oxygen (DO) >40%.
• Termination Cue: Transition at late-exponential phase (OD600 ~50-60) or upon glucose exhaustion.

Phase II: Production Phase

Objective: Maximize flux through the FAB pathway. Protocol:

• Medium Exchange: Rapid centrifugation or microfiltration to replace spent growth medium with production medium.
• Production Medium: Defined, often carbon-limited but with precursor boosters (e.g., 20 g/L glycerol, 5 g/L ethanol, 1 g/L acetate, excess pantothenate (CoA precursor), and biotin (acetyl-CoA carboxylase cofactor)).
• Conditions: May use mild stress to induce lipid accumulation (e.g., T = 25°C, nitrogen limitation, controlled hypoxia).
• Induction: If using an inducible system, add chemical inducer (e.g., galactose for pGAL1, anhydrotetracycline for pTET) at transition.

Table 2: Typical Two-Phase Fermentation Parameters for FAB in S. cerevisiae

Parameter	Growth Phase	Production Phase	Rationale
Carbon Source	40 g/L Glucose	20 g/L Glycerol + 5 g/L Ethanol	Reduces Crabtree effect; glycerol enhances redox balance (NADH→NADPH).
C/N Ratio	8:1	50:1 (N-limited)	Nitrogen limitation triggers storage lipid synthesis.
Temperature	30°C	25°C	Mild cold stress can increase unsaturated fatty acid yield.
Dissolved O2	>40%	5-20% (Controlled)	Low O2 can mimic hypoxia, inducing lipid storage genes.
pH	5.5	6.5	Slightly higher pH may stabilize key enzymes.
Duration	18-24 hr	48-72 hr	Extended production time for pathway flux.

Integrated Strategy: Combining Dynamic Regulation with Two-Phase Fermentation

The most effective approach layers genetic dynamic control onto the two-phase process.

Experimental Workflow Protocol:

• Strain Construction: Engineer yeast with (a) a galactose-inducible ACC1 (acetyl-CoA carboxylase) variant, and (b) a hypoxia-responsive (pDAN1) promoter driving FAS1.
• Phase I (Growth): Ferment in synthetic complete medium with 40 g/L raffinose (non-inducing) at 30°C, DO 50%.
• Phase Transition: At OD600 ~55, harvest cells via tangential flow filtration and resuspend in production medium (N-limited, 20 g/L galactose + 10 g/L glycerol).
• Phase II (Production): Operate bioreactor at 25°C, DO 10%. Galactose induces ACC1, and low DO induces pDAN1-FAS1.
• Analytics: Sample periodically for GC-MS analysis of fatty acid methyl esters (FAMEs) and transcriptomics.

Diagram Title: Integrated Two-Phase Fermentation with Dynamic Pathway Induction

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for FAB Pathway Optimization in S. cerevisiae

Item	Function/Benefit	Example Product/Supplier
S. cerevisiae Fatty Acid Synthase (FAS) Inhibitor (Cerulenin)	Tool for probing FAB flux and validating engineered increases in flux; inhibits β-ketoacyl-ACP synthase.	MilliporeSigma C2389
Acetyl-CoA Carboxylase (ACC1) Assay Kit	Quantify activity of this rate-limiting FAB enzyme under different dynamic control strategies.	Cell Biolabs, Inc. (Metabolite Assay Kit)
NADPH/NADP+ Fluorometric Assay Kit	Monitor redox cofactor balance, critical for FAB which consumes NADPH.	BioVision K347-100
Fatty Acid Methyl Ester (FAME) GC-MS Standard Mix	Essential for quantifying and profiling fatty acid products via GC-MS.	Supelco 37 Component FAME Mix
Yeast Synthetic Drop-out Media Supplements	For selective maintenance of plasmids and genomic integrations in engineered strains.	Sunrise Science Products
Galactose/Raffinose Carbon Source Blends	For precise control of inducible systems (e.g., pGAL) during two-phase fermentation.	MilliporeSigma G0750 / R0250
Acyl-Homoserine Lactone (AHL) Quorum Sensing Molecules	Inducers for LuxI/LuxR-based dynamic regulation systems.	Cayman Chemical Company
Biotin (Vitamin B7) Supplement	Cofactor for ACC1; adding excess can relieve a potential bottleneck.	MilliporeSigma B4639
RNA-seq Library Prep Kit for Yeast	For transcriptomic analysis of dynamic gene expression during phase shift.	Illumina Stranded Total RNA Prep

Resolving the growth-production trade-off is paramount for the industrial application of yeast fatty acid biosynthesis. The synergistic application of dynamic genetic regulation—using metabolite, quorum, or hypoxia sensors—within a structured two-phase fermentation process provides a robust framework to maximize volumetric productivity. This strategy directly supports the broader thesis that temporal and conditional control over metabolic pathway expression is essential for efficient microbial chemical production in pharmaceutical development.

Benchmarking and Target Validation: S. cerevisiae as a Model for Fungal and Human Disease Research

This whitepaper provides a comparative analysis of fatty acid synthase (FAS) architectures, framed within a broader thesis investigating the fatty acid biosynthesis pathway in Saccharomyces cerevisiae. Understanding the structural and functional distinctions between the Type I megasynthase (FAS I) found in S. cerevisiae, its mammalian counterpart (FASN), and the dissociated Type II system (FAS II) in bacteria is crucial for fundamental biochemistry and applied drug discovery.

System Architectures & Quantitative Comparison

Table 1: Core Comparative Characteristics of FAS Systems

Feature	S. cerevisiae FAS I	Mammalian FASN	Bacterial FAS II
System Type	Type I, Iterative	Type I, Iterative	Type II, Dissociated
Genomic Organization	FAS1 (β-subunit) & FAS2 (α-subunit) genes	Single FASN gene	Discrete genes for each enzyme
Complex Stoichiometry	α6β6	X-shaped Dimer (primarily)	Monomeric/oligomeric independent enzymes
Molecular Mass	~2.6 MDa	~540 kDa (monomer)	15 - 50 kDa per enzyme
ACP Type	Acyl Carrier Protein (ACP) domain	Acyl Carrier Protein (ACP) domain	Discrete, soluble ACP protein
Primary Product	C16/C18 saturated fatty acids	C16 palmitate	Diverse (C10-C20), varies by species
Regulation	Transcriptional (Inositol/Choline), Metabolic	Hormonal (Insulin), Transcriptional (SREBP1c), Allosteric	Transcriptional (FadR, FabR), Feedback inhibition
Key Drug Target	Not a primary antifungal target	Target for metabolic disorders, cancer	Target for novel antibacterial agents

Table 2: Key Enzymatic Domains/Activities Comparison

Activity/Domain	S. cerevisiae FAS I (Locations)	Mammalian FASN (Locations)	Bacterial FAS II (Protein)
Acetyltransferase	α-subunit (loading)	MAT domain	FabH (β-ketoacyl-ACP synthase III)
Malonyltransferase	α-subunit (loading)	MAT domain	FabD (malonyl-CoA:ACP transacylase)
β-Ketoacyl Synthase	β-subunit (KS)	KS domain	FabB, FabF (KAS I/II)
β-Ketoacyl Reductase	α-subunit (KR)	KR domain	FabG
Dehydratase	β-subunit (DH)	DH domain	FabA, FabZ
Enoyl Reductase	β-subunit (ER)	ER domain	FabI (primary)
Thioesterase	Independent (Tes1)	TE domain	No direct analog; termination varies

Experimental Protocols for Key Analyses

3.1. Protocol: FAS Complex Purification (S. cerevisiae) Objective: Isolate intact α6β6 FAS I complex for structural or kinetic studies.

• Strain & Culture: Use wild-type S. cerevisiae (e.g., BY4741). Grow in YPD to mid-log phase (OD600 ~1.0).
• Cell Lysis: Harvest cells, wash, and resuspend in Lysis Buffer (50 mM HEPES pH 7.5, 100 mM KCl, 1 mM EDTA, 10% glycerol, 1 mM PMSF, protease inhibitors). Lyse using a high-pressure homogenizer or bead beater.
• Clarification: Centrifuge lysate at 100,000 x g for 1 hour at 4°C.
• Ammonium Sulfate Precipitation: Precipitate proteins with 40% saturated (NH4)2SO4. Resuspend pellet in Buffer A (20 mM HEPES pH 7.5, 100 mM KCl, 1 mM EDTA, 10% glycerol).
• Size Exclusion Chromatography (SEC): Load onto a Superose 6 Increase column equilibrated with Buffer A. The intact FAS complex elutes in the void volume (~2.6 MDa).
• Validation: Analyze fractions by SDS-PAGE (showing ~210 kDa α and ~220 kDa β subunits) and native PAGE for complex integrity. Confirm activity via NADPH oxidation assay.

3.2. Protocol: In Vitro Fatty Acid Synthesis Assay (Radioactive) Objective: Measure FAS activity and product profile from different systems.

• Reaction Mix: Assemble in 100 µL: 50 mM Potassium Phosphate (pH 6.8), 1 mM DTT, 1 mM EDTA, 0.2 mM acetyl-CoA, 0.5 mM malonyl-CoA, 0.5 mM NADPH, 0.1 mM [2-14C]malonyl-CoA (specific activity 50 mCi/mmol). For FAS II, include 50 µM E. coli ACP.
• Initiation: Add purified enzyme complex (FAS I/FASN) or reconstituted FAS II enzyme mix (FabD, FabH, FabG, FabZ, FabI, ACP). Incubate at 30°C (yeast/bacteria) or 37°C (mammalian) for 30 min.
• Termination & Extraction: Stop with 100 µL of 5M KOH. Saponify at 80°C for 1 hour. Acidify with 6M HCl and extract fatty acids with 500 µL hexane.
• Analysis: Spot hexane extract on a silica TLC plate. Develop in hexane:diethyl ether:acetic acid (70:30:1, v/v/v). Visualize and quantify radioactive fatty acid methyl ester (FAME) spots using a phosphorimager.

3.3. Protocol: CRISPR-Cas9 Knockout of FASN in Mammalian Cells Objective: Generate FASN-deficient cell lines to study pathway reliance.

• Design gRNAs: Design two gRNAs targeting essential exons of the human FASN gene. Clone into a Cas9-GFP expression plasmid (e.g., pSpCas9(BB)-2A-GFP).
• Transfection: Transfect HEK293T or target cancer cell line using lipid-based transfection reagent.
• Sorting: 48h post-transfection, sort single GFP-positive cells into 96-well plates using FACS.
• Screening: Expand clonal lines. Screen for knockout via:
  • Western Blot: Anti-FASN antibody.
  • Genomic PCR: Amplify targeted region; indels cause smearing.
  • Sanger Sequencing: Confirm frameshift mutations.
• Phenotypic Validation: Assess growth in lipid-depleted media supplemented with exogenous palmitate (C16:0).

Visualizations

Diagram 1: Architectural Comparison of FAS Systems

Diagram 2: Iterative Catalytic Cycle in FAS I/FASN

Diagram 3: Experimental Workflow for Comparative FAS Analysis

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents and Materials for FAS Research

Reagent/Material	Function/Application	Example (Supplier)
Malonyl-CoA, [2-14C]	Radiolabeled substrate for in vitro FAS activity assays; quantifies fatty acid synthesis.	PerkinElmer, American Radiolabeled Chemicals
Anti-FASN Antibody	Detection and quantification of mammalian FASN protein via Western blot, IHC.	Cell Signaling Technology (C20G5)
NADPH, Tetrasodium Salt	Essential cofactor for the KR and ER reduction steps in FAS.	MilliporeSigma
Acetyl-CoA, Li Salt	Starter substrate for fatty acid synthesis.	Avanti Polar Lipids
E. coli Acyl Carrier Protein (ACP)	Essential cofactor for in vitro reconstitution of bacterial FAS II system.	Avanti Polar Lipids (purified)
Cerulenin	Natural product inhibitor of β-ketoacyl synthase (KS) domains; tool compound for FAS I/FASN inhibition studies.	Cayman Chemical
C75 (trans-C75)	Synthetic inhibitor of mammalian FASN; used in cancer metabolism studies.	Tocris Bioscience
Triclosan	Broad-spectrum inhibitor of bacterial enoyl reductase (FabI); FAS II-specific tool.	MilliporeSigma
Superose 6 Increase 10/300 GL	Size-exclusion chromatography column for separating intact FAS I megacomplex.	Cytiva
Lipid-Depleted Fetal Bovine Serum	For cell culture experiments requiring control of exogenous fatty acid supply.	Thermo Fisher Scientific
CRISPR-Cas9 FASN Knockout Kit	Pre-designed gRNAs and controls for generating FASN-null mammalian cell lines.	Santa Cruz Biotechnology (sc-400647)
Fatty Acid Methyl Ester (FAME) Mix	GC/MS standard for identifying fatty acid products from FAS assays.	Supelco (37 Component FAME Mix)

1. Introduction: Framing within S. cerevisiae Fatty Acid Biosynthesis Research

Within the broader thesis on the Fatty Acid Biosynthesis (FAB) pathway in Saccharomyces cerevisiae, validating the essentiality of the cytosolic Fatty Acid Synthase (FAS) complex is a foundational pillar. Unlike higher eukaryotes where FAS is a single, large polypeptide, fungal FAS is a massive, barrel-shaped multi-enzyme complex (Type I FAS), making it a structurally distinct and promising antifungal target. This whitepaper provides a technical guide for experimentally validating FAS as a drug target and for characterizing established and novel inhibitors, thereby bridging pathway biochemistry with translational drug discovery.

2. Target Validation: Demonstrating FAS Essentiality in S. cerevisiae

2.1 Genetic Knockout/Depletion Strategies

• Protocol: Tet-Off Promoter System for Conditional Gene Depletion
  • Strain Engineering: Replace the native promoter of an essential FAS gene (e.g., FAS1 or FAS2) in a haploid S. cerevisiae strain with a tetracycline/doxycycline-repressible promoter (e.g., pTET).
  • Culture Conditions: Inoculate the engineered strain in synthetic complete medium with (+Dox) and without (-Dox) doxycycline (typically 10 µg/mL).
  • Growth Monitoring: Measure optical density (OD600) every 2 hours over 24-48 hours. Perform serial dilutions and spot assays on solid media ± Dox.
  • Phenotypic Analysis: Assess cell morphology via microscopy (e.g., membrane integrity stains like propidium iodide, lipid droplet staining with Nile Red) following promoter shut-off.
• Expected Data: Growth cessation and loss of viability upon promoter repression confirm essentiality for in vitro growth.

2.2 Chemical-Genetic Validation with Specific Inhibitors Using established FAS inhibitors provides orthogonal validation.

• Protocol: Spot Assay for Inhibitor Sensitivity
  • Prepare a logarithmic-phase culture of wild-type (WT) S. cerevisiae (e.g., BY4741) in YPD, adjusting to OD600 ~0.5.
  • Perform a 10-fold serial dilution series (10⁰ to 10⁻⁵) in sterile water.
  • Spot 3-5 µL of each dilution onto YPD agar plates containing a gradient or fixed concentration of inhibitor (e.g., Cerulenin at 5, 10, 25 µg/mL; Triclosan at 1, 5, 10 µM). Include a DMSO/solvent control plate.
  • Incubate at 30°C for 48-72 hours and document growth.

Table 1: Summary of Key FAS Inhibitors for Validation Studies

Inhibitor	Target Site in FAS	Typical Working Conc. in S. cerevisiae	Expected Phenotype	Key Mechanism
Cerulenin	β-ketoacyl synthase (KS) domain of Fas1/Fas2	5-25 µg/mL	Total growth inhibition; reduced lipid content	Irreversible covalent binding to the active site cysteine.
Triclosan	Enoyl reductase (ER) domain of Fas1	5-20 µM	Growth defect; altered membrane composition	Competitive inhibition of NAD⁺ binding.
C75 (trans-)	β-ketoacyl synthase (KS)	50-200 µM (less potent in yeast)	Moderate growth inhibition	Reversible, non-covalent inhibition.

3. Detailed Methodologies for Testing FAS Inhibitors

3.1 In Vitro Enzyme Inhibition Assay (Microplate-Based)

• Protocol: NADPH Oxidation Assay for FAS Activity
  • FAS Preparation: Purify the FAS complex from S. cerevisiae (e.g., via differential centrifugation and gel filtration) or purchase a commercial preparation. Keep on ice.
  • Reaction Mix: In a 96-well plate, add per well: 50 mM potassium phosphate buffer (pH 6.8), 1 mM EDTA, 0.1 mM acetyl-CoA, 0.2 mM malonyl-CoA, 0.3 mM NADPH. Add inhibitor (varying concentrations) or vehicle control.
  • Initiation & Reading: Start the reaction by adding purified FAS (10-50 µg protein). Immediately monitor the decrease in absorbance at 340 nm (for NADPH consumption) every 30 seconds for 10-15 minutes at 30°C using a plate reader.
  • Analysis: Calculate initial reaction velocities. Determine IC₅₀ values by fitting inhibitor concentration vs. normalized velocity data to a sigmoidal dose-response curve.

3.2 Ex Vivo Metabolomic & Lipidomic Profiling

• Protocol: GC-MS Analysis of Fatty Acid Composition Post-Inhibition
  • Treatment & Harvest: Grow WT S. cerevisiae to mid-log phase. Treat with IC₈₀ concentration of inhibitor (e.g., Cerulenin) or DMSO for 2-3 generations. Harvest cells by rapid filtration.
  • Lipid Extraction & Derivatization: Use a Bligh & Dyer extraction. Saponify lipids and methylate free fatty acids to Fatty Acid Methyl Esters (FAMEs) using boron trifluoride-methanol.
  • GC-MS Analysis: Inject FAMEs onto a polar column (e.g., DB-23). Use a temperature gradient. Identify peaks by comparison to standards and mass spectra libraries.
  • Data Quantification: Normalize peak areas to internal standard (e.g., C17:0) and cell dry weight.

Table 2: Expected Lipidomic Changes in S. cerevisiae Upon FAS Inhibition

Parameter	Cerulenin Treatment	Triclosan Treatment	Commentary
Total Cellular Fatty Acids	Sharp decrease (>60%)	Moderate decrease (30-50%)	Reflects direct block of synthesis.
C16:0 / C18:0 Ratio	Increased	May increase	KS inhibition stalls chain elongation.
Unsaturated Fatty Acid %	May increase (compensatory)	Can be altered	Feedback on desaturase activity (OLE1).
Odd-Chain/Unusual FA	Possible appearance	Less common	Malonyl-CoA decarboxylation or precursor diversion.

4. The Scientist's Toolkit: Research Reagent Solutions

Item/Category	Function in FAS Research	Example/Note
Tet-Off Yeast Strains	Conditional depletion of FAS genes (FAS1, FAS2).	Essential for genetic essentiality proof. Commercial kits available.
Purified S. cerevisiae FAS Complex	In vitro enzymatic assays and direct inhibitor screening.	Can be purified from overproducing strains or obtained commercially.
Cerulenin	Gold-standard, covalent FAS inhibitor for positive controls.	Light-sensitive; prepare fresh stock in ethanol.
Triclosan	Specific Enoyl Reductase (ER) domain inhibitor.	Stock in DMSO or ethanol. Also inhibits bacterial FabI.
Malonyl-CoA & Acetyl-CoA	Natural substrates for FAS activity assays.	Critical for in vitro activity measurements; costly.
NADPH	Cofactor for FAS reducing steps (KR, ER).	Monitor oxidation at A340 for activity readout.
Nile Red / BODIPY 493/503	Neutral lipid droplet staining for phenotypic analysis.	Indicator of lipid metabolism disruption.
GC-MS System with Polar Column	For definitive fatty acid composition and profiling.	Key for lipidomic validation of inhibitor effect in vivo.

5. Visualizing Pathways and Workflows

Title: FAS Pathway & Inhibitor Targets in S. cerevisiae

Title: FAS Target Validation & Inhibitor Testing Workflow

Leveraging Yeast Genetics to Study Human FASN Dysregulation in Cancer and Metabolic Disorders

Within the broader thesis on the Fatty Acid Biosynthesis (FAB) pathway in Saccharomyces cerevisiae, this whitepaper details how this genetically tractable model is uniquely positioned to deconvolute the pathophysiology of human Fatty Acid Synthase (FASN) dysregulation. Human FASN, a multi-enzyme complex, is often overexpressed in cancers and metabolic disorders, driving lipogenesis for membrane biogenesis, signaling molecules, and energy storage. The core thesis posits that the highly conserved structure and regulation of the FAB pathway in yeast, centered on the FAS1 and FAS2 genes (encoding the β- and α-subunits of FAS, respectively), provide a simplified yet relevant system for functional analysis of human FASN (hFASN) variants, discovery of genetic modifiers, and high-throughput drug screening.

Conserved Pathway Architecture & Quantitative Comparison

The core enzymatic steps from acetyl-CoA and malonyl-CoA to palmitate (C16:0) are conserved. Key quantitative differences are summarized below.

Table 1: Quantitative Comparison of FASN/FAS in Human vs. S. cerevisiae

Feature	Human FASN (hFASN)	S. cerevisiae FAS (ScFAS)	Experimental Implication for Yeast Models
Structure	Homodimer of ~270 kDa multifunctional polypeptides.	α6β6 heterododecamer; FAS1 (β, ~220 kDa), FAS2 (α, ~250 kDa).	Yeast allows discrete manipulation of α and β subunit genes.
Carrier Protein	Acyl Carrier Protein (ACP) domain integrated into each monomer.	Separate ACP domain encoded within the FAS2 gene.	Yeast ACP can be studied as a discrete functional unit.
Product Primarily Released as	Palmitic acid (free fatty acid).	Palmitoyl-CoA.	Complementation assays must account for release mechanism.
Cellular Localization	Cytosolic.	Cytosolic.	Conservation simplifies functional substitution studies.
Typical Activity (in vitro)	~100-200 nmol/min/mg (cancer cell lines).	~500-1000 nmol/min/mg (purified enzyme).	Yeast system offers robust signal for genetic/chemical screens.
Regulation	Transcriptional (SREBP1), post-translational (Ubiquitination, phosphorylation by kinases like AMPK, AKT).	Transcriptional (Inositol/choline regulation), metabolic feedback (palmitoyl-CoA).	Yeast provides a clean background to reconstitute human regulatory nodes.

Key Experimental Protocols

Protocol 1: Humanization of Yeast FAS via Plasmid Shuffle for Functional Complementation.

• Objective: To test the function of wild-type or mutant hFASN alleles in a yeast cell devoid of endogenous FAS activity.
• Materials: Yeast strain with chromosomal deletion of FAS1 or FAS2, covered by a wild-type copy on a URA3-marked plasmid (e.g., pRS416-FAS1). A LEU2-marked plasmid (e.g., pRS415) expressing hFASN cDNA.
• Method:
  • Transform the yeast strain with the hFASN-LEU2 plasmid.
  • Plate transformants on synthetic complete medium lacking leucine (-Leu) to select for the hFASN plasmid.
  • Perform plasmid shuffle by streaking grown colonies onto medium containing 5-Fluoroorotic Acid (5-FOA). 5-FOA is toxic to cells retaining the URA3 plasmid (covering the endogenous FAS deletion).
  • Viable colonies on 5-FOA plates indicate that the hFASN plasmid complements the essential function of yeast FAS.
  • Growth phenotypes (slow growth, auxotrophies) are quantified to assess functional efficiency of hFASN variants.
• Application: Determining pathogenicity of hFASN SNPs found in metabolic disorders or cancer.

Protocol 2: High-Throughput Synthetic Genetic Array (SGA) to Identify Modifiers of hFASN-Induced Toxicity.

• Objective: Identify yeast gene deletions that enhance or suppress cellular defects caused by dysregulated hFASN expression.
• Materials: Query strain expressing hFASN (or a hyperactive mutant) with selectable markers (e.g., kanMX). Yeast non-essential gene deletion library (e.g., MATa haploids with natMX).
• Method:
  • Mate the query strain with the arrayed library of deletion mutants using a robotic pinner.
  • Transfer diploids to sporulation medium.
  • Pin spores to medium selecting for haploid progeny carrying both the query marker (kanMX) and the library deletion marker (natMX), and lacking counter-selection markers.
  • Scan colony sizes after 48-72 hours of growth. Compare to a control SGA with empty vector.
  • Deletion mutants producing very small (synthetic sick) or very large (suppressor) colonies are identified as genetic interactors.
• Application: Uncover genetic networks and potential drug targets that buffer hFASN dysregulation.

Protocol 3: In vivo Lipidomic Profiling via LC-MS/MS in Engineered Yeast Strains.

• Objective: Quantify changes in fatty acid species and related metabolites upon expression of oncogenic hFASN mutants.
• Materials: Yeast strains (wild-type, fasΔ + hFASN-WT, fasΔ + hFASN-Oncomutant). Internal standards (e.g., deuterated fatty acids). LC-MS/MS system.
• Method:
  • Grow yeast cultures to mid-log phase in defined medium.
  • Rapidly harvest cells, quench metabolism (liquid N2), and perform lipid extraction via Folch or Bligh & Dyer method with added internal standards.
  • Analyze extracts using reversed-phase C18 chromatography coupled to a tandem mass spectrometer operating in multiple reaction monitoring (MRM) mode.
  • Quantify fatty acyl species (C12:0 - C18:0, including saturated and unsaturated), and acyl-CoAs by comparing peak areas to internal standards.
  • Perform statistical analysis (e.g., ANOVA) to identify significant metabolite changes.
• Application: Characterize metabolic rewiring driven by hFASN dysregulation, identifying unique lipid signatures.

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Reagents for Yeast-Based hFASN Research

Reagent / Material	Function & Application	Key Considerations
Yeast FAS Deletion Strains (fas1Δ, fas2Δ with cover plasmid)	Essential host background for functional complementation assays with hFASN.	Ensure cover plasmid is stable and has a counterselectable marker (e.g., URA3 for 5-FOA shuffle).
hFASN Expression Plasmids (Yeast 2μ or CEN/ARS vectors)	For constitutive or inducible expression of hFASN alleles in yeast.	Codon-optimization of hFASN cDNA for yeast can dramatically improve expression and complementation.
5-Fluoroorotic Acid (5-FOA)	Selective agent for plasmid shuffle; counterselects against URA3-marked cover plasmid.	Critical for isolating yeast colonies reliant solely on hFASN for fatty acid synthesis.
Cerulenin	A natural product inhibitor of the β-ketoacyl synthase (KS) domain of FAS.	Used as a positive control for FAS inhibition in growth assays and validating chemical screens.
Defined Lipid/Sterol Supplements (e.g., Tween 80/Polysorbate 80, Ergosterol)	To rescue auxotrophies and fine-tune fatty acid requirements in complementation tests.	Allows dissection of specific fatty acid product requirements (e.g., saturated vs. unsaturated).
Yeast Deletion Library (Non-essential or Conditional)	Genome-wide resource for SGA analysis to find genetic interactors of hFASN.	Enables unbiased discovery of pathways that buffer hFASN dependency or toxicity.
Fatty Acid & Acyl-CoA Internal Standards (Deuterated, e.g., D31-Palmitate)	Essential for absolute quantification in lipidomic LC-MS/MS profiling.	Ensures accuracy by correcting for extraction efficiency and instrument variability.
Anti-hFASN Monoclonal Antibody (e.g., Clone C20G5)	To verify hFASN protein expression and stability in yeast lysates via Western blot.	Confirm antibody cross-reactivity is specific and does not detect yeast FAS subunits.

This whitepaper explores the translational potential of fundamental research on the Fatty Acid Biosynthesis (FAS) pathway in Saccharomyces cerevisiae for the development of novel antifungals. The core thesis posits that the essentiality, conservation, and mechanistic plasticity of FAS between baker's yeast and human fungal pathogens like Candida albicans and Aspergillus fumigatus make it an exemplary system for "model-to-host" drug discovery. Insights into enzyme structure, regulation, and essentiality in S. cerevisiae provide a validated roadmap for targeting homologous pathways in pathogens, accelerating lead identification and mechanistic validation.

The Conserved Fatty Acid Synthase (FAS) Machinery

FAS in fungi is a type I multifunctional enzyme complex, distinct from the dissociated type II system in bacteria and plants, offering selectivity for drug targeting. The S. cerevisiae FAS is a 2.6 MDa α~6~β~6~ dodecamer, with α-subunit (Fas2) harboring β-ketoacyl synthase (KS), β-ketoacyl reductase (KR), and phosphopantetheinyl transferase domains, and the β-subunit (Fas1) containing acyl carrier protein (ACP), malonyl/palmitoyl transferase (MPT), dehydratase (DH), enoyl reductase (ER), and palmitoyl thioesterase (PT) domains.

Table 1: Conservation of FAS Core Domains Between S. cerevisiae and Major Pathogens

FAS Domain	S. cerevisiae Gene	C. albicans Ortholog	A. fumigatus Ortholog	% Amino Acid Identity (vs. S.c.)	Essentiality (Pathogen)
β-ketoacyl synthase (KS)	FAS2	FAS2	FasA	~65% (C.a.), ~60% (A.f.)	Essential (Both)
Acyl Carrier Protein (ACP)	FAS1	FAS1	FasB	~70% (C.a.), ~68% (A.f.)	Essential (Both)
Enoyl Reductase (ER)	FAS1	FAS1	FasB	~72% (C.a.), ~67% (A.f.)	Essential (Both)
Dehydratase (DH)	FAS1	FAS1	FasB	~68% (C.a.), ~62% (A.f.)	Essential (Both)
β-ketoacyl Reductase (KR)	FAS2	FAS2	FasA	~75% (C.a.), ~70% (A.f.)	Essential (Both)
Malonyl Transferase (MT)	FAS1	FAS1	FasB	~66% (C.a.), ~61% (A.f.)	Essential (Both)

Key Experimental Protocols from Model to Pathogen

Protocol 1: Heterologous Complementation Assay for Functional Conservation

• Objective: Determine if an Aspergillus or Candida FAS gene can rescue the lethal phenotype of an S. cerevisiae FAS null mutant, confirming functional homology.
• Methodology:
  • Clone the candidate pathogen FAS gene (e.g., C. albicans FAS2) into an S. cerevisiae expression plasmid under a galactose-inducible (GAL1) promoter.
  • Transform the plasmid into a heterozygous S. cerevisiae FAS2/fas2Δ diploid strain. Select transformants on appropriate dropout media.
  • Perform sporulation and tetrad dissection on inducing media (+Galactose, -Ura) to select haploid progeny carrying both the plasmid and the chromosomal deletion.
  • Test for complementation via a "shut-off" assay on glucose media (represses GAL1 promoter). Growth indicates the pathogen's gene provides essential FAS function.
• Interpretation: Successful rescue confirms the pathogen's gene product can integrate into the S. cerevisiae FAS complex and perform its enzymatic role, validating it as a drug target.

Protocol 2: High-Throughput Screening of Inhibitors Using a Yeast FAS-Reporter Strain

• Objective: Identify compounds that specifically inhibit fungal FAS.
• Methodology:
  • Utilize an S. cerevisiae strain with a FAS1 or FAS2 promoter fused to a luciferase or GFP reporter. FAS inhibition leads to transcriptional upregulation of these genes via feedback loops.
  • Grow the reporter strain in 384-well plates to mid-log phase.
  • Dispense compound libraries (e.g., 10 µM final concentration) using an automated system. Include controls: DMSO (negative), cerulenin (KS inhibitor, positive).
  • Incubate for 6-8 hours, measure luminescence/fluorescence. A significant increase in signal indicates potential FAS inhibition.
  • Counter-screen against a bacterial (type II FAS) reporter in E. coli to exclude non-specific inhibitors and prioritize fungal-specific hits.
• Interpretation: Hits from this primary screen are then validated in secondary assays with pathogenic fungi.

Protocol 3: Structural Validation by Homology Modeling and Docking

• Objective: Predict the binding mode of a lead inhibitor to the pathogen's FAS using the S. cerevisiae FAS crystal structure as a template.
• Methodology:
  • Retrieve the high-resolution X-ray structure of S. cerevisiae FAS (e.g., PDB: 6EK2).
  • Generate a homology model of C. albicans or A. fumigatus FAS target domain (e.g., KR) using SWISS-MODEL or MODELLER.
  • Prepare the protein structure (add hydrogens, assign charges) and the 3D structure of the lead compound using molecular modeling software (e.g., Schrödinger Maestro, AutoDock Tools).
  • Perform molecular docking simulations to predict binding pose and affinity (kcal/mol).
  • Validate predictions by site-directed mutagenesis of predicted contact residues in the S. cerevisiae FAS, followed by enzymatic or growth inhibition assays.

Visualizing the Translational Workflow and Pathway

Diagram Title: Model-to-Pathogen Translational Research Workflow

Diagram Title: Fungal FAS Pathway with Inhibitor Targets

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Reagents for FAS Translational Research

Reagent / Material	Function / Role	Example/Source
Heterozygous Yeast Deletion Strains	Essential for complementation assays (e.g., BY4743 FAS2/fas2Δ).	Yeast Knockout Strain Collection (e.g., EUROSCARF).
Galactose-Inducible Expression Vectors	For controlled expression of pathogen FAS genes in S. cerevisiae (e.g., pYES2/NT).	Thermo Fisher Scientific, Addgene.
FAS-Specific Inhibitors (Tool Compounds)	Positive controls for inhibition assays. Cerulenin (KS inhibitor), AFN-1252 (KR inhibitor).	Sigma-Aldrich (Cerulenin), research chemical suppliers.
Reporter Plasmids	For constructing promoter-GFP/luciferase fusions (e.g., pYM-N44-GFP for C-terminal tagging).	Yeast resource centers (ATCC, EUROSCARF).
Crystal Structure of S.c. FAS	Template for homology modeling (PDB IDs: 6EK2, 2UV9, 2P8F).	Protein Data Bank (RCSB PDB).
Homology Modeling & Docking Software	For in silico target analysis and inhibitor binding prediction.	SWISS-MODEL (web), MODELLER, AutoDock Vina.
Microplate Reader with Luminescence	For high-throughput screening of FAS-reporter strains.	Instruments like Tecan Spark, BMG Labtech PHERAstar.
Site-Directed Mutagenesis Kit	For validating predicted inhibitor contact residues in FAS domains.	Q5 Site-Directed Mutagenesis Kit (NEB).

The microbial production of fatty acids and their derivatives in Saccharomyces cerevisiae represents a promising, sustainable route for pharmaceuticals, nutraceuticals, and biofuels. Evaluating the performance of engineered yeast strains requires a rigorous, multi-faceted approach centered on the core metrics of Titer, Rate, and Yield (TRY), with a clear pathway to industrial scalability. This guide details the quantitative framework and experimental protocols essential for benchmarking strains within the context of fatty acid pathway engineering.

Core TRY Metrics: Definitions and Targets

The TRY triad forms the cornerstone of bioprocess economics.

• Titer: The concentration of the target product (e.g., free fatty acids, fatty alcohols) in the fermentation broth at the end of the process, typically given in grams per liter (g/L). High titer reduces downstream purification costs.
• Rate: The speed of product formation, expressed as volumetric productivity (g/L/h) or specific productivity (g/g cells/h). High rate increases bioreactor throughput.
• Yield: The efficiency of substrate conversion into product, expressed as grams of product per gram of substrate (g/g). High yield maximizes resource utilization and minimizes raw material costs.

For fatty acid production in S. cerevisiae, recent advances have pushed boundaries, as summarized in Table 1.

Table 1: Representative Performance Metrics for Engineered S. cerevisiae Fatty Acid Producers

Engineered Target / Strategy	Max Titer (g/L)	Max Productivity (g/L/h)	Max Yield (g/g glucose)	Key Limitation Addressed	Reference (Example)
Acetyl-CoAOverexpression of acetyl-CoA synthase, cytosolic acetyl-CoA pathway	1.2	0.025	0.04	Precursor supply	[Lian et al., Metab Eng, 2018]
NADPH SupplyOverexpression of pentose phosphate pathway enzymes (Zwf1, Gnd1)	10.5	0.12	0.098	Redox cofactor imbalance	[Chen et al., Nat Commun, 2023]
Fatty Acid Synthase (FAS)Engineered FAS for medium-chain fatty acids	0.8	0.015	0.03	Product chain-length specificity	[Gajewski et al., PNAS, 2023]
TAG & β-oxidationDeletion of DGA1, ARE1/2; controlled lipase expression	2.5	0.05	0.065	Product sequestration & degradation	[Leber & Da Silva, Curr Opin Biotech, 2022]
Multi-factorialAcetyl-CoA + NADPH + FAS + Transport	15.7	0.18	0.12	Integrated pathway optimization	[Recent Patent, WO202401...]

Detailed Experimental Protocols for TRY Assessment

Fed-Batch Fermentation for Titer & Rate Determination

• Objective: To determine maximum achievable titer and volumetric productivity under controlled, nutrient-sufficient conditions.
• Protocol:
  • Inoculum Prep: Grow engineered S. cerevisiae strain overnight in synthetic complete (SC) medium with 20 g/L glucose.
  • Bioreactor Setup: Inoculate a 1-L bioreactor (e.g., DasGip, Sartorius) containing defined medium with initial 20 g/L glucose to an OD600 of 0.1. Set conditions: pH 5.5 (controlled with NH4OH), 30°C, dissolved oxygen (DO) >30% via cascaded agitation/aeration.
  • Feeding Phase: Initiate exponential glucose feed (500 g/L stock) once batch glucose is depleted (indicated by DO spike). Maintain growth at a set µ (e.g., 0.15 h⁻¹) to avoid overflow metabolism.
  • Sampling: Take periodic samples (every 2-4 h) for OD600, substrate, and product analysis.
  • Analysis: Quantify fatty acids via GC-FID/MS after derivatization (e.g., to FAMEs). Calculate volumetric productivity as the slope of the product concentration vs. time plot during the linear production phase. Final titer is the concentration at harvest.

Carbon-Limited Chemostat for Yield Determination

• Objective: To measure the true stoichiometric yield (Y_p/s) under steady-state, nutrient-limited conditions devoid of metabolic shifts.
• Protocol:
  • Setup: Operate a continuous stirred-tank reactor (CSTR) at a working volume of 0.5 L. Use defined medium with a limiting carbon source (e.g., 5 g/L glucose). All other nutrients are in excess.
  • Dilution Rate: Set a constant dilution rate (D) below the critical dilution rate (e.g., D = 0.10 h⁻¹) to avoid washout.
  • Steady State: Allow at least 5 vessel volumes to pass to achieve steady state (constant OD600 and metabolite concentrations).
  • Sampling & Calculation: Collect effluent over 24h. Measure residual glucose (HPLC) and product titer (GC). Calculate Yield (Y_p/s) as: (Product concentration in effluent) / (Feed substrate concentration – Residual substrate concentration in effluent).

Pathway and Workflow Visualization

Diagram 1: Fatty acid biosynthesis and metabolic engineering targets

Diagram 2: Strain evaluation workflow: from lab to scale-up

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Materials for Fatty Acid Pathway Engineering & Analysis

Item / Reagent	Function / Application	Example Vendor(s)
Yeast Synthetic Drop-out Mix (Complete/-Leu/-Ura)	For selective maintenance of plasmids and genomic edits in engineered S. cerevisiae strains.	Sunrise Science, MP Biomedicals
CRISPR-Cas9 System for Yeast	High-efficiency toolkit for gene knockouts, integrations, and point mutations.	Addgene (plasmids), Synthego (gRNAs)
GC-FID/MS System with FAME Column	Gold-standard for quantifying and identifying fatty acids after methyl ester derivatization.	Agilent (HP-88 column), Restek
Fatty Acid Methyl Ester (FAME) Standards	Calibration and identification of fatty acid products from yeast cultures.	Supelco 37 Component FAME Mix
Enzymatic NADP/NADPH Assay Kit	Quantifying cytosolic redox cofactor levels critical for FAS activity.	BioVision, Sigma-Aldrich
Acetyl-CoA / Malonyl-CoA Assay Kit	Measuring intracellular precursor pool sizes for fatty acid synthesis.	Cell Technology Inc., Abcam
Defined Fermentation Medium (C/N Trace)	For reproducible, high-density fed-batch and chemostat cultivations.	ForMedium, custom formulation
Lipid Extraction Solvents (Chloroform, Methanol)	For Bligh & Dyer total lipid extraction prior to FA analysis.	Honeywell, Sigma-Aldrich
Anti-FLAG/HA Magnetic Beads	For immunopurification and analysis of tagged FAS complex proteins.	Sigma-Aldrich, Thermo Fisher
RNA-seq Library Prep Kit	Transcriptomic analysis of engineered strains under production conditions.	Illumina, Thermo Fisher

Assessing Industrial Scalability

Scalability assessment moves beyond TRY to include:

• Strain Robustness: Performance in non-ideal conditions (pH, temperature fluctuations, impurity tolerance).
• Media & Feedstock Cost: Utilization of low-cost, non-refined carbon sources (e.g., molasses, hydrolysates).
• Product Recovery: Ease of separation from broth; toxicity to production host.
• Process Intensity: Oxygen demand, heat generation, and foaming characteristics observed in pilot-scale (>50 L) fermenters.

A promising strain for fatty acid production must demonstrate not only high TRY in controlled lab fermentations but also maintain a favorable economic profile when these scaling factors are incorporated into techno-economic analysis (TEA).

Research into the fatty acid biosynthesis (FAS) pathway in Saccharomyces cerevisiae has traditionally focused on understanding its regulatory mechanisms for fundamental cell biology and for producing modest amounts of lipids, primarily for membrane integrity. The FAS I system in S. cerevisiae, a large, multi-functional enzyme complex, is tightly regulated by acetyl-CoA carboxylase (ACC1) and fatty acid synthase (FAS1, FAS2). A key thesis in this field posits that while S. cerevisiae possesses the core enzymatic machinery for lipid production, its natural regulatory networks prioritize carbohydrate metabolism and suppress excessive lipid accumulation. This context sets the stage for comparing the inherent limitations of S. cerevisiae as a future metabolic engineering vector against the native prowess of oleaginous yeasts like Yarrowia lipolytica and Rhodosporidium toruloides, which naturally redirect carbon flux towards triacylglycerol (TAG) storage under nutrient stress.

Core Physiological & Metabolic Comparison

Oleaginous yeasts are defined by their ability to accumulate lipids exceeding 20% of their dry cell weight (DCW). This capability stems from distinct metabolic and regulatory adaptations.

Key Comparative Traits:

• Carbon Flux & Precursor Supply: Oleaginous yeasts maintain a continuous supply of cytosolic acetyl-CoA and NADPH, the key precursors for FAS. Y. lipolytica utilizes a ATP:citrate lyase (ACL)-dependent pathway, cleaving mitochondrially-derived citrate in the cytosol to yield acetyl-CoA and oxaloacetate. S. cerevisiae lacks a functional ACL.
• Lipid Body Structure & TAG Assembly: Oleaginous yeasts possess more sophisticated and numerous lipid bodies. The TAG synthesis pathway, particularly the "Kennedy pathway," exhibits higher intrinsic activity and different isoforms of key enzymes like diacylglycerol acyltransferases (DGATs).
• Nitrogen Starvation Trigger: Oleaginous metabolism is induced by nitrogen limitation in the presence of excess carbon. This leads to a dramatic drop in cellular AMP, inhibiting the NAD+-dependent isocitrate dehydrogenase (IDH). This causes citrate accumulation, export to cytosol, and subsequent ACL-driven acetyl-CoA production.

Table 1: Physiological and Metabolic Parameters of Yeast Species

Parameter	S. cerevisiae (Non-Oleaginous)	Y. lipolytica (Oleaginous)	R. toruloides (Oleaginous)
Max Lipid Content (% DCW)	Typically 10-15%	Can exceed 50-60%	Can exceed 60-70%
Preferred Carbon Sources	Glucose, Sucrose, Galactose	Glucose, Glycerol, Alkanes, Fatty Acids	Glucose, Xylose, Lignocellulosic hydrolysates
Cytosolic Acetyl-CoA Route	Pyruvate dehydrogenase bypass (PDH bypass: Pyruvate → Acetaldehyde → Acetate → Acetyl-CoA)	ATP: Citrate Lyase (ACL) pathway	ATP: Citrate Lyase (ACL) pathway
Native FAS System	Type I (Multi-functional protein complex)	Type I	Type I & II (separate enzymes for some steps)
Major Storage Lipid	Sterol Esters, TAG	Triacylglycerols (TAG)	Triacylglycerols (TAG)
Byproduct Formation	Ethanol (Crabtree-positive)	Citric Acid, Polyols	Carotenoids (e.g., β-carotene, torulene)

Experimental Protocols for Comparative Analysis

Protocol 1: Determination of Lipid Content (Gravimetric Analysis)

• Inoculation & Cultivation: Inoculate yeast strains in nitrogen-rich medium (e.g., YPD) overnight. Harvest cells, wash, and re-inoculate into Nitrogen-Limited Medium (NLM) with high C:N ratio (>50:1) (e.g., 60 g/L glucose, 0.5 g/L ammonium sulfate). Incubate at 30°C, 200 rpm for 72-120h.
• Harvesting & Drying: Harvest cells by centrifugation (4000 x g, 10 min). Wash twice with deionized water. Lyophilize or dry at 80°C to constant weight to obtain Dry Cell Weight (DCW).
• Lipid Extraction (Modified Folch Method): Weigh ~50 mg of dry biomass. Add 2:1 (v/v) chloroform:methanol mixture (4 mL). Sonicate or vortex vigorously for 30 min. Add 1 mL of 0.9% NaCl solution, vortex, and centrifuge (3000 x g, 10 min) for phase separation.
• Solvent Evaporation & Quantification: Carefully collect the lower organic phase. Evaporate chloroform under nitrogen stream or rotary evaporation. Weigh the residual lipid. Calculate lipid content as (weight of lipid / DCW) x 100%.

Protocol 2: Analysis of Fatty Acid Profile (GC-FID)

• Transesterification: Dissolve ~10 mg of extracted lipid in 1 mL of toluene. Add 2 mL of 1% sulfuric acid in methanol. Incubate at 50°C for 16 hours (or 80°C for 2h with shaking).
• Extraction of FAMEs: Cool, add 1 mL of water and 1 mL of hexane. Vortex and centrifuge. Collect the upper hexane layer containing Fatty Acid Methyl Esters (FAMEs).
• Gas Chromatography: Analyze using GC equipped with FID and a polar capillary column (e.g., DB-WAX). Use a temperature gradient (e.g., 140°C to 240°C). Identify peaks by comparison with FAME standards.

Genetic & Metabolic Engineering Landscapes

S. cerevisiae remains a prime chassis for exploratory pathway engineering due to its unparalleled genetic toolbox (CRISPR, extensive libraries, well-characterized promoters). Current thesis research often involves engineering S. cerevisiae to mimic oleaginous traits: heterologously expressing ACL genes (from Y. lipolytica or Mus musculus), overexpressing ACC1 and DGAT (DGA1), and deleting competing pathways (e.g., β-oxidation POX1, glycerol-3-phosphate dehydrogenase GPD1).

Y. lipolytica has a mature, sophisticated toolkit including CRISPR-Cas9, strong promoters (pTEF, hp4d), and a tendency for non-homologous end joining (NHEJ) requiring KU70 deletion for efficient homologous recombination. Engineering focuses on pushing yields further by enhancing acetyl-CoA supply (ACL, PDH, malic enzyme), expanding substrate range, and manipulating lipid droplet-associated proteins.

R. toruloides presents challenges (e.g., inefficient transformation, diploid genome) but its toolkit is advancing rapidly with CRISPR-Cas9 systems now reported. Its natural co-production of lipids and carotenoids is a major research focus.

Table 2: Engineering Outcomes for Lipid Production (Representative Recent Data)

Yeast Species	Engineering Strategy	Cultivation Mode/Substrate	Lipid Titer (g/L)	Lipid Content (% DCW)	Key Reference Insight (2022-2024)
S. cerevisiae	Overexpression of ACC1, DGA1; Δgpd1, Δpox1; Heterologous ACL	Batch, Glucose	4.5 - 8.2	~25-35%	Demonstrates feasibility but requires extensive rewiring.
Y. lipolytica	Δku70; Multiple gene copies of DGA1, GPD1; Acetyl-CoA overproduction	Fed-batch, Glucose	>100	60-70%	Industrial-scale production demonstrated.
R. toruloides	Engineered nitrogen sensing (Δure2); Enhanced acetyl-CoA supply	Batch, Lignocellulosic sugars	25 - 35	~65%	Showcases strength in using complex, non-food feedstocks.

Visualization: Pathways and Workflows

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Materials and Reagents

Item	Function / Application	Example/Notes
Nitrogen-Limited Medium (NLM)	Induces oleaginous phenotype by creating high C:N ratio.	Contains high glucose (e.g., 60-80 g/L) and low ammonium sulfate (e.g., 0.1-0.5 g/L). May require trace elements.
Chloroform-Methanol (2:1 v/v)	Lipid extraction solvent based on Folch method. Effectively solubilizes neutral and polar lipids.	Highly toxic. Use in fume hood with appropriate PPE.
Fatty Acid Methyl Ester (FAME) Mix	Standard for calibrating GC-FID to identify and quantify individual fatty acids (C14-C24).	Supelco 37 Component FAME Mix is commonly used.
Trichloroacetic Acid (TCA)	For rapid quenching of metabolism during metabolomics studies of acetyl-CoA and intermediate pools.	Typically used at cold 60% (w/v) solution.
Lyophilizer (Freeze Dryer)	For obtaining accurate Dry Cell Weight (DCW) by removing all water without degrading heat-sensitive lipids.	Alternative: Oven drying at 80°C to constant weight.
CRISPR-Cas9 System Kit	For genetic engineering (knock-out, knock-in) in non-model yeasts like R. toruloides.	Includes species-specific codon-optimized Cas9, gRNA expression cassette, and donor DNA templates.
Anti-Lipid Droplet Protein Antibody	For visualizing and quantifying lipid body dynamics via fluorescence microscopy (e.g., immunostaining).	Targets proteins like Pln1p in Y. lipolytica or Erg6p in S. cerevisiae.
Acetyl-CoA Assay Kit (Fluorometric)	For quantifying intracellular acetyl-CoA levels, a critical precursor metric.	Based on enzymatic conversion and detection of fluorescent product.

Conclusion

The fatty acid biosynthesis pathway in S. cerevisiae represents a paradigmatic system where deep foundational knowledge enables powerful methodological applications. From its unique Type I FAS architecture to its intricate regulatory network, understanding this pathway is crucial for both basic science and industrial biotechnology. Methodological advances allow precise engineering of yeast as cellular factories for renewable chemicals and fuels, though optimization requires careful troubleshooting of metabolic bottlenecks. Furthermore, the conservation and divergence of FAS components make S. cerevisiae an indispensable model for validating antifungal targets and gaining insights into human diseases like cancer and obesity. Future research will likely focus on dynamic control systems, harnessing non-conventional yeasts, and developing yeast-based platforms for screening next-generation therapeutics that target lipid metabolism, thereby cementing its role at the intersection of synthetic biology and biomedical discovery.